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Description
[0001] The present invention relates to an improved process for the specific production of poly-unsaturated ω-3 and
ω-6 fatty acids and a process for the production of triglycerides having an increased content of unsaturated fatty acids,
in particular ω-3 and ω-6 fatty acids having at least two double bonds and a 20 or 22 carbon atom chain length. The
invention relates to the production of a transgenic oil producing a plant, having an increased content of fatty acids, oils
or lipids containing C20- or C22- fatty acids with a Δ5, 7, 8, 10 double bond, respectively due to the expression of a Δ8-
desaturase and a Δ9- elongase from organisms such as plants preferably Algae like Isochrysis galbana or Euglena
gracilis. In addition the invention relates to a process for the production of poly unsaturated fatty acids such as Eicos-
apentaenoic, Arachidonic, Docosapentaenoic or Docosahexaenoic acid through the co- expression of a Δ-8-desaturase,
a Δ-9-elongase and a Δ-5 desaturase in organisms such as plants.
[0002] The invention additionally relates to the use of specific nucleic acid sequences encoding for the aforementioned
proteins with Δ-8-desaturase-, Δ-9-elongase- or Δ-5-desaturase-activity, nucleic acid constructs, vectors and organisms
containing said nucleic acid sequences. Also disclosed are unsaturated fatty acids and triglycerides having an increased
content of at least 1 % by weight of unsaturated fatty acids and use thereof.
[0003] Fatty acids and triglycerides have numerous applications in the food industry, animal nutrition, cosmetics and
in the drug sector. Depending on whether they are free saturated or unsaturated fatty acids or triglycerides with an
increased content of saturated or unsaturated fatty acids, they are suitable for the most varied applications; thus, for
example, polyunsaturated fatty acids (= PUFAs) are added to infant formula to increase its nutritional value. The various
fatty acids and triglycerides are mainly obtained from microorganisms such as Mortierella or from oil-producing plants
such as soybean, oilseed rape, sunflower and others, where they are usually obtained in the form of their triacylglycerides.
Alternatively, they are obtained advantageously from animals, such as fish. The free fatty acids are prepared advanta-
geously by hydrolysis.
[0004] Whether oils with unsaturated or with saturated fatty acids are preferred depends on the intended purpose;
thus, for example, lipids with unsaturated fatty acids, specifically polyunsaturated fatty acids, are preferred in human
nutrition since they have a positive effect on the cholesterol level in the blood and thus on the possibility of heart disease.
They are used in a variety of dietetic foodstuffs or medicaments. In addition PUFAs are commonly used in food, feed
and in the cosmetic industry. Poly unsaturated ω-3-and/or ω-6-fatty acids are an important part of animal feed and human
food. Because of the common composition of human food poly unsaturated ω-3-fatty acids, which are an essential
component of fish oil, should be added to the food to increase the nutritional value of the food; thus, for example, poly
unsaturated fatty acids such as Docosahexaenoic acid (= DHA, C22:6Δ4,7,10,13,16,19) or Eicosapentaenoic acid (= EPA,
C20:5Δ5,8,11,14,17) are added as mentioned above to infant formula to increase its nutritional value. Whereas DHA has a
positive effect of the brain development of babies. The addition of poly unsaturated ω-3-fatty acids is preferred as the
addition of poly unsaturated ω-6-fatty acids like Arachidonic acid (= ARA, C20:4Δ5,8,11,14) to common food have an
undesired effect for example on rheumatic diseases such as rheumatoid arthritis. Poly unsaturated w-3- and ω-6-fatty
acids are precursor of a family of paracrine hormones called eicosanoids such as prostaglandins which are products of
the metabolism of Dihomo-γ-linoleic acid, ARA or EPA. Eicosanoids are involved in the regulation of lipolysis, the initiation
of inflammatory responses, the regulation of blood circulation and pressure and other central functions of the body.
Eicosanoids comprise prostaglandins, leukotrienes, thromboxanes, and prostacyclins. ω-3-fatty acids seem to prevent
artherosclerosis and cardiovascular diseases primarily by regulating the levels of different eicosanoids. Other Eicosanoids
are the thromboxanes and leukotrienes which are products of the metabolism of ARA or EPA.
[0005] Principally microorganisms such as Mortierella or oil producing plants such as soybean, rapeseed or sunflower
or algae such as Crytocodinium or Phaeodactylum are a common source for oils containing PUFAs, where they are
usually obtained in the form of their triacyl glycerides. Alternatively, they are obtained advantageously from animals,
such as fish. The free fatty acids are prepared advantageously by hydrolysis with a strong base such as potassium or
sodium hydroxide. Higher poly unsaturated fatty acids such as DHA, EPA, ARA, Dihomo-γ-linoleic acid (C20:3Δ8,11,14)
or Docosapentaenoic acid (= DPA, C22:5Δ7,10,13,16,19) are not produced by oil producing plants such as soybean, rape-
seed, safflower or sunflower. A natural sources for said fatty acids are fish for example herring, salmon, sardine, redfish,
eel, carp, trout, halibut, mackerel, pike-perch or tuna or algae.
[0006] On account of their positive properties there has been no shortage of attempts in the past to make available
genes which participate in the synthesis of fatty acids or triglycerides for the production of oils in various organisms
having a modified content of unsaturated fatty acids. Thus, in WO 91/13972 and its US equivalent a Δ-9-desaturase is
described. In WO 93/11245 a Δ-15-desaturase and in WO 94/11516 a Δ-12-desaturase is claimed. WO 00/34439
discloses a Δ-5- and a Δ-8-desaturase. Other desaturases are described, for example, in EP-A-0 550162, WO 94/18337,
WO 97/30582, WO 97/21340, WO 95/18222, EP-A-0 794 250, Stukey et al., J. Biol. Chem., 265,1990: 20144-20149,
Wada et al., Nature 347, 1990: 200-203 or Huang et al., Lipids 34, 1999: 649-659. To date, however, the various
desaturases have been only inadequately characterized biochemically since the enzymes in the form of membrane-
bound proteins are isolable and characterizable only with very great difficulty (McKeon et al., Methods in Enzymol. 71,
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1981: 12141-12147, Wang et al., Plant Physiol. Biochem., 26,1988: 777-792). Generally, membrane-bound desaturases
are characterized by introduction into a suitable organism which is then investigated for enzyme activity by means of
analysis of starting materials and products. Δ-6-Desaturases are described in WO 93/06712, US 5,614,393, US 5614393,
WO 96/21022, WO0021557 and WO 99/27111 and their application to production in transgenic organisms is also
described, e.g. in WO 9846763, WO 9846764 and WO 9846765. At the same time the expression of various fatty acid
biosynthesis genes, as in WO 9964616 or WO 9846776, and the formation of poly-unsaturated fatty acids is also
described and claimed.
[0007] From US2002/0138874 A1 the identification and uses of several genes involved in the elongation of monoun-
saturated fatty acids, especially a functionally active elongase, which utilize a monounsaturated fatty acid as a substrate
is known. WO 02/077213 A3 describes an elongase gene encoding a polypeptide which elongates α-linolenic acid by
at least two carbon atoms whereas γ-linolenic acid is not elongated.
[0008] With regard to the effectiveness of the expression of desaturases and their effect on the formation of polyun-
saturated fatty acids it may be noted that through expression of desaturases and elongases as described to date only
low contents of poly-unsaturated fatty acids/lipids, such as by way of example eicosapentaenoic or archidonic acid, have
been achieved. Therefore, an alternative and more effective pathway with higher product yield is desirable.
[0009] Accordingly, ther is still a great demand for new and more suitable genes which encode enzymes which par-
ticipate in the biosynthesis of unsaturated fatty acids and make it possible to produce certain fatty acids specifically on
an industrial scale without unwanted byproducts forming. In the selection of genes for biosynthesis two characteristics
above all are particularly important. On the one hand, there is as ever a need for improved processes for obtaining the
highest possible contents of polyunsaturated fatty acids.
[0010] Accordingly, it is an object of the present invention to provide further genes of desaturase and elongase enzymes
for the synthesis of polyunsaturated fatty acids in organisms preferably in microorganisms and plants and to use them
in a commercial process for the production of poly unsaturated fatty acids. Said process should increase PUFA content
in organisms as much as possible preferably in seeds of an oil producing plant.
[0011] We have found that this object is achieved by a process for the production of compounds of the following
general formula
in transgenic oil producing plant with a content of at least 1 % by weight of said compounds referred to the total lipid
content of said oil producing plant which comprises the following steps:
a) introduction of at least one nucleic acid sequence in a transgenic oil producing plant, which encodes a Δ-9-
elongase having a nucleic acid sequence depicted in SEQ ID NO:3, and
b) introduction of at least one second nucleic acid sequence which encodes a Δ-8-desaturase having a nucleic acid
sequence depicted in SEQ ID NO:1, and
c) if necessary introduction of at least a third nucleic acid sequence, which encodes a Δ-5-desaturase having a
nucleic acid sequence depicted in SEQ ID NO:5, 7 or 9, and
d) cultivating and harvesting of said oil producing plant; and
where the variables and substituents in formula I have the following meanings:
R1 = hydroxyl-, Coenzyme A-(Thioester), phosphatidylcholine-, phosphatidylethanolamine-, phosphatidylglycer-
ol-, diphosphatidylglycerol-, phosphatidylserine-, phosphatidylinositol-, sphingolipid-, glycoshingolipid- or a
residue of the general formula II:
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where the substituents in formula II have the following meanings:
R2 = hydrogen-, phosphatidylcholine-, phosphatidylethanolamine-, phosphatidylglycerol-, diphosphatidylg-
lycerol-, phosphatidylserine-, phosphatidylinositol-, shingolipid-, glycoshingolipid-, glycoshingolipid-
or saturated or unsaturated C2-C24-alkylcarbonyl-,
R3 = hydrogen-, saturated or unsaturated C2-C24-alkylcarbonyl-, or
R2 and R3 independent of each other a residue of the formula la:
n = 3,4 or 6, m = 3, 4 or 5 and p = 0 or 3, preferably n = 3, m = 4 or 5 and p = 0 or 3.
R1 indicates in the formula I hydroxyl-, Acetyl-Coenzyme A-, phosphatidylcholine-, phosphatidyleth-
anolamine-, phosphatidylglycerol-, diphosphatidylglycerol-, phosphatidylserine-, phosphatidylinosi-
tol-, sphingolipid-, glycoshingolipid- or a residue of the general formula II
[0012] The abovementioned residues for R1 are always coupled to compounds of the general formula I in the form of
their ester or thioester.
[0013] R2 indicates in structures of the general formula II hydrogen, phosphatidylcholine-, phosphatidylethanolamine-,
phosphatidylglycerol-, diphosphatidylglycerol-, phosphatidylserine-, phosphatidylinositol-, shingolipid-, glycoshingolip-
id-, glycoshingolipid- or saturated or unsaturated C2-C24-alkylcarbonyl-residues,
[0014] Alkyl radicals which may be mentioned are substituted or unsubstituted, saturated or unsaturated C2-C24-alkyl-
carbonyl- chains such as ethylcarbonyl-, n-propylcarbonyl-, n-butylcarbonyl-, n-pentylcarbonyl-, n-hexylcarbonyl-, n-
heptylcarbonyl-, n-octyl-carbonyl-, n-nonylcarbonyl-, n-decylcarbonyl-, n-undecylcarbonyl-, n-dodecylcarbonyl-, n-tride-
cylcarbonyl-, n-tetradecylcarbonyl-, n-pentadecylcarbonyl-, n-hexadecylcarbonyl-, n-heptadecylcarbonyl-, n-octadecyl-
carbonyl-, n-nonadecylcarbonyl-, n-eicosylcarbonyl-, n-docosanylcarbonyl- or n-tetracosanylcarbonyl-, that contain one
or more double bonds. Saturated or unsaturated C10-C22-Alkylcarbonylresidues such as n-decylcarbonyl-, n-undecyl-
carbonyl-, n-dodecylcarbonyl-, n-tridecylcarbonyl-, n-tetra-decylcarbonyl-, n-pentadecylcarbonyl-, n-hexadecylcarbo-
nyl-, n-heptadecylcarbonyl-, n-octadecylcarbonyl-, n-nonadecylcarbonyl-, n-eicosylcarbonyl-, n-docosanyl-carbonyl- or
n-tetracosanylcarbonyl- are preferred, which contain one ore more double bonds. In particular privileged are saturated
or unsaturated C10-C22-alkylcarbonyl-residue as C10-alkylcarbonyl-, C11-alkylcarbonyl-, C12-alkylcarbonyl-, C13-alkyl-
carbonyl-, C14-alkylcarbonyl-, C16-alkylcarbonyl-, C18-alkylcarbonyl-, C20-alkylcarbonyl-, C22-alkylcarbonyl- or C24-alkyl-
carbonyl-residue, that contain one ore more double bonds. In particular privileged are saturated or unsaturated
C16-C22-alkylcarbonylresidue as C16-alkylcarbonyl-, C18-alkylcarbonyl-, C20-alkylcarbonyl- or C22-alkylcarbonyl-residue,
that contain one ore more double bonds. The residues contain in particular two, three, four or five double bonds. Par-
ticularly preferred are residues of 20 or 22 carbon atoms having up to five double bonds, preferably three, four or five
EP 1 576 166 B1
5
5
10
15
20
25
30
35
40
45
50
55
double bonds. All residues are derived from the mentioned corresponding fatty acids.
[0015] R3 indicates in structures of the general formula II hydrogen, saturated or unsaturated C2-C24-alkylcarbonyl.
[0016] Substituted or unsubstituted, saturated or unsaturated C2-C24-alkylcarbonyl- residues are e. g. ethylcarbonyl-,
n-propylcarbonyl-, n-butylcarbonyl-, n-pentylcarbonyl-, n-hexyl-carbonyl-,n-heptylcarbonyl-, n-octylcarbonyl-, n-nonyl-
carbonyl-, n-decylcarbonyl-, n-undecylcarbonyl-, n-dodecylcarbonyl-, n-tridecylcarbonyl-, n-tetradecylcarbonyl-, n-pen-
tadecylcarbonyl-, n-hexadecylcarbonyl-, n-heptadecylcarbonyl-, n-octadecylcarbonyl-, n-nonadecylcarbonyl-, n-eicosyl-
carbonyl-, n-docosanylcarbonyl- or n-tetracosanylcarbonyl-, having one or more double bonds. Preferred are saturated
or unsaturated C10-C24-alkylcarbonyl residues as n-decylcarbonyl-, n-undecylcarbonyl-, n-dodecylcarbonyl-, n-tridecyl-
carbonyl-, n-tetradecylcarbonyl-, n-pentadecylcarbon yl-, n-hexadecylcarbonyl-, n-heptadecylcarbonyl-, n-octadecylcar-
bonyl-, n-nonadecylcarbonyl-, n-eicosylcarbonyl-, n-docosanylcarbonyl- or n-tetracosanylcarbonyl-, with one ore more
double bonds. In particular saturated or unsaturated C10-C24-alkylcarbonyl residues as C10-alkylcarbonyl-, C11-alkyl-
carbonyl-, C12-alkylcarbonyl-, C13-alkylcarbonyl-, C14-alkylcarbonyl-, C16-alkylcarbonyl-, C18-alkylcarbonyl-, C20-alkyl-
carbonyl-, C22-alkylcarbonyl- or C24-alkylcarbonyl-residues with one or more double bonds. In particular preferred are
saturated or unsaturated C16-C22-alkylcarbonylresidue as C16-alkylcarbonyl-, C18-alkylcarbonyl-, C20-alkylcarbonyl- or
C22-alkylcarbonyl-residues, with multiple double bonds. C18-alkylcarbonyl-residues are particularly preferred, which
contain one, two, three or four double bonds and C20-alkylcarbonyl-residues, with three, four or five double bonds. All
residues are derived from the corresponding fatty acids.
[0017] R2 and R3 indicates in structures of the general formula II independent of each other a residue of the general
formula la
whereas the variables in the formula I and Ia are defined as: n = 3,4 or 6, m = 3, 4 or 5 and p = 0 or 3. In particular: n =
3, m = 4 or 5 and p = 0 or 3.
[0018] The abovementioned residues R1, R2 and R3 can be substituted with hydoxyl- or epoxy-groups or might contain
also triple bonds.
[0019] According to the invention the used nucleic acid sequences are isolated nucleic sequences coding for polypep-
tides having C20- Δ5- or Δ-8 desaturase or C18- Δ9-elongase activity.
[0020] The according to inventive process synthesized substances of formula I which contain as residue R1 the residue
of formula II contain preferentially a mixture of different residues R2 or R3. The residues are derived from different fatty
acid molecules as short chain fatty acids with 4 to 6 C-atoms, mid-chain fatty acids having 8 to 12 C-atoms and long-
chain fatty acids with 14 to 24 C-atoms, whereas the long-chain fatty acids are preferred. Said long chain fatty acids are
derived preferentially from C18- or C20-poly unsaturated fatty acids having advantageously between two and five double
bonds. In addition the backbone of formula I is also derived from such a aforementioned fatty acid which advantageously
is also different from R2 and R3. That means compounds which are produced by the inventive process are in one aspect
of the invention triglycerides of different substituted or unsubstituted, saturated or unsaturated fatty acid ester or thioesters.
[0021] Also disclosed are poly-unsaturated fatty acid esters (of the formula I) with 18, 20 or 22 fatty acid carbon atoms
chain length with at least two double bonds, preferably three, four or five are particularly preferred.
[0022] In particular fatty acid molecules with three, four or five double bonds are preferred for the synthesis of eicosa-
dienoic, eicosatrienoic, eicosatetranoic (arachidonic-acid) and eicosapentanoic acid (C20:2n-6, Δ11, 14; C20:3n-6, Δ8,
11, 14; C20:4n-6, Δ5, 8, 11, 14, C20:3n-3, Δ11, 14, 17; C20:4n-3, Δ8, 11, 14, 17; C20:5n-3, Δ5, 8, 11, 14, 17) in the
inventive process, whereas arachidonic acid and eicosapentaenoic acid are most preferred. We have found that this
object is advantageously achieved by the combined expression of three isolated nucleic acid sequences according to
the invention which encode for polypeptides having the following activities: a polypeptides with C20-Δ-8-desaturase
activity, a C18-Δ-9-elongase activity, and a C20-Δ-5 desaturase activity. This objective was achieved in particular by the
co-expression of the isolated nucleic acid sequences according to the invention. C18 fatty acids with a double bond in
Δ-9-position are elongated by the Δ-9-elongase advantageously used in the inventive process. By the Δ-8-desaturase
used in the process a double in Δ-8-position is introduced into C20 fatty acids. In addition a double bond can be introduced
into the fatty acid molecules in Δ-5-position by the Δ-5-desaturase.
[0023] The fatty acid ester of C18-, C20- and/or C22-poly unsaturated fatty acids synthesized in the inventive process
advantageously in form of their triglycerides as ester or thioesters can be isolated from the producing organism for
example from a microorganism or a plant in the form of an oil, lipid or lipid mixture for example as sphingolipids, phos-
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phoglycerides, lipids, glycolipids such as glycosphingolipids, phospholipids such as phosphatidylethanolamine, phos-
phatidylcholine, phosphatidylserine, phosphatidylglycerol, phosphatidylinositol or diphosphatidylglycerol, or as monoa-
cylglyceride, diacylglyceride or triacylglyceride or as other fatty acid esters such as acetyl-Coenzym A thioester, which
contain saturated or unsaturated fatty acids preferably poly unsaturated fatty acids with at least two preferably at least
three double bonds in the fatty acid molecule. In addition to the in form of the aforementioned esters bound fatty acids
also fatty acids bound in other compounds can be produced or also free fatty acids can be produced by the inventive
process.
[0024] In general the transgenic oil producing plants used in the inventive process contain fatty acid esters or fatty
acids in a distribution of nearly 80 to 90 % by weight of triacyl glycerides, 2 to 5 % by weight diacyl glycerides, 5 to 10
% by weight monoacyl glycerides, 1 to 5 % by weight free fatty acids and 2 to 8 % by weight phospholipids, whereas
the total amount of the aforementioned compounds are all together a 100 % by weight.
[0025] In the inventive process(es) [the singular shall include the plural and vice versa] at least 1 % by weight, preferably
at least 2, 3, 4 or 5 % by weight, more preferably at least 6, 7, 8, or 9 % by weight, most preferably 10, 20 or 30 % by
weight of the compounds of formula I referred to the total lipid content of the organism used in the process are produced.
Preferred starting material for the inventive process are linoleic acid (C18:2) and/or linolenic acid (C18:3) which are
transformed to the preferred end products ARA or EPA. As for the inventive process organisms are used the product of
the process is not a product of one pure substance per se. It is a mixture of different substances of formula I where one
or more compounds are the major product and others are only contained as side products. In the event that in an
organism used in the process linoleic and linolenic acid are available the end product is a mixture of ARA and EPA.
Advantageously the side products shall not exceed 20 % by weight referred to the total lipid content of the organism,
preferably the side products shall not exceed 15 % by weight, more preferably they shall not exceed 10 % by weight,
most preferably they shall not exceed 5 % by weight. Preferably organisms are used in the process which contain as
starting material either linoleic or linolenic acid so that as end product of the process only ARA or EPA are produced. In
the event EPA and ARA are produced together, they should be produced in a ratio of at least 1:2 (EPA:ARA), preferably
of at least 1:3, more preferably of at least 1:4, most preferably of at least 1:5. In the event that a mixture of different fatty
acids such as ARA and EPA are the product of the inventive process said fatty acids can be further purified by method
known by a person skilled in the art such as distillation, extraction, crystallization at low temperatures, chromatography
or a combination of said methods.
[0026] In principle all host organisms can be used in the inventive process for example transgenic organisms such as
plants like mosses; green, red, brown or blue algae; monocotyledons or dicotyledones. Advantageously oil producing
Transgenic algae, mosses or plants are used in the inventive processes described herein (for the invention the singular
shall include the plural and vice versa), Additional advantageously organisms are plants or parts thereof. Plants are
preferably used, very particularly preferably plants such as oilseed plants containing high amounts of lipid compounds
such as rapeseed, poppy, mustard, hemp, castor bean, sesame, olive, calendula, punica, hazel nut, almond, macadamia,
avocado, pumpkin, walnut, laurel, pistachio, primrose, canola, peanut, linseed, soybean, safflower, sunflower, borage
or plants such as maize, wheat, rye, oat, triticale, rice, barley, cotton, manihot, pepper, tagetes, solanaceaous plants
such as potato, tobacco, eggplant, and tomato, Vicia species, pea, alfalfa, bushy plants (coffee, cacao, tea), Salix
species, trees (oil palm, coconut) and perennial grasses and forage crops. Particularly preferred plants of the invention
are oilseed plants rapeseed, poppy, mustard, hemp, castor bean, sesame, olive, calendula, punica, hazel nut, almond,
macadamia, avocado, pumpkin, laurel, pistachio, primrose, canola, peanut, linseed, soybean, safflower, sunflower,
borage or trees (oil palm, coconut). Most preferred are C18-2- and/or C18:3-fatty acid rich plants such as hemp, sesame,
linseed, poppy, pumpkin, walnut, tobacco, cotton, safflower or sunflower.
[0027] Depending on the nucleic acid and/or the organism used in the inventive processes different compounds of
the general formula I can be synthesized. In addition depending on the plant used in the process different mixtures of
formula I compounds or single compounds such as arachidonic acid or eicosapentaenoic acid in free or bound form can
be produced. In the event that in the inventive processes organism are used which have as precursor of the fatty acid
synthesis preferably C18:2- or C18:3-fatty acids different poly unsaturated fatty acids can be synthesized for example
starting from C18:2-fatty acids γ-linoleic acid, dihomo-γ-linoleic acid or arachidonic acid can be produced or starting from
C18:3-fatty acids stearidonic acid, eicosatetraenoic acid or eicosapentaenoic acid can be produced. By influencing the
activity of the different genes or their gene products different single compounds or compound mixtures can be produced.
As living organisms are used in the inventive process the crude material that means crude lipids and/or oils isolated
from the organisms preferably contain at least some starting compounds such as C18:2- or C18:3-fatty acids or their
combination in the product and depending on the activity of the nucleic acid sequences and their gene products fatty
acid intermediates of the biosynthesis chain. Said starting compounds or intermediates are in the product in a concen-
tration of less than 20 or 15 % by weight, preferably less than 10, 9, 8, 7 or 6 % by weight, more preferably less than 5,
4, 3, 2 or 1 % by weight of the total fatty acids isolated from the used organism.
[0028] Transgenic plants are to be understood as meaning single plant cells and their cultures on solid media or in
liquid culture, parts of plants and entire plants such as plant cell cultures, protoplasts from plants, callus cultures or plant
EP 1 576 166 B1
7
5
10
15
20
25
30
35
40
45
50
55
tissues such as leafs, shoots, seeds, flowers, roots etc. Said transgenic plants can be cultivated for example on solid
or liquid culture medium, in soil or in hydroponics.
[0029] After cultivation transgenic plants which are used in the inventive process can be brought to the market without
isolating compounds of the general formula I. Preferably the compounds of the general formula I are isolated from the
organisms in the form of their free fatty acids, their lipids or oils. The purification can be done by conventional methods
such as squeezing and extraction of the plants or other methods instead of the extraction such as distillation, crystallization
at low temperatures, chromatography or a combination of said methods. Advantageously the plants are grinded, heated
and/or vaporized before the squeezing and extraction procedure. As solvent for the extraction solvents such as hexane
are used. The isolated oils are further purified by acidification with for example phosphoric acid. The free fatty acids are
produced from said oils or lipids by hydrolysis. Charcoal or diatom earth are used to remove dyes from the fluid. In
another preferred embodiment of the inventive process the alkyl ester of the fatty acids are produced from the oils and
lipids by transesterification with an enzyme of with conventional chemistry. A preferred method is the production of the
alkyl ester in the presence of alcohalates of the corresponding lower alcohols (C1 to C10 alcohols such as methanol,
ethanol, propanol, butanol, hexanol etc.) such as methanolate or ethanolate. Therefore as the skilled worker knows the
alcohol in the presence of a catalytic amount of a base such as NaOH or KOH is added to the oils or lipids.
[0030] It is also disclosed that the lipids can be obtained in the usual manner after the organisms have been grown.
To this end, the organisms can first be harvested and then disrupted, or they can be used directly. It is advantageous
to extract the lipids with suitable solvents such as apolar solvents, for example hexane, or polar solvents, for example
ethanol, isopropanol, or mixtures such as hexane/isopropanol, phenol/chloroform/isoamyl alcohol, at temperatures be-
tween 0°C and 80°C, preferably between 20°C and 50°C. As a rule, the biomass is extracted with an excess of solvent,
for example with an excess of solvent to biomass of 1:4. The solvent is subsequently removed, for example by distillation.
The extraction may also be carried out with supercritical CO2. After the extraction, the remainder of the biomass can be
removed, for example, by filtration. Standard methods for the extraction of fatty acids from plants and microorganisms
are described in Bligh et al. (Can. J. Biochem. Physiol. 37, 1959: 911-917) or Vick et al. (Plant Physiol. 69,
1982:1103-1108).
[0031] The crude oil thus obtained can then be purified further, for example by removing cloudiness by adding polar
solvents such as acetone or apolar solvents such as chloroform, followed by filtration or centrifugation. Further purification
via columns or other techniques is also possible.
[0032] To obtain the free fatty acids from the triglycerides, the latter are hyrolyzed in the customary manner, for example
using NaOH or KOH.
[0033] In the process oils, lipids and/or free fatty acids or fractions thereof are produced. Said products can be used
for the production of feed and food products, cosmetics or pharmaceuticals.
[0034] In principle all nucleic acids encoding polypeptides with Δ-8-desaturase, Δ-9-elongase and/or Δ-5-desaturase
activity can be used in the inventive process. Preferably the nucleic acid sequences can be isolated for example from
microorganism or plants such as fungi like Mortierella, algae like Euglena, Crypthecodinium or Isochrysis, diatoms like
Phaeodactylum or mosses like Physcomitrella or Ceratodon, but also non-human animals such as Caenorhabditis are
possible as source for the nucleic acid sequences. Advantageous nucleic acid sequences which encode polypeptides
having a Δ-8-desaturase, Δ-9-elongase and/or Δ-5-desaturase activity are originate from microorganisms or plants,
advantageously Phaeodactylum tricomutum, Ceratodon purpureus, Physcomitrella patens, Euglena gracilis or Isochrysis
galbana. Euglena gracilis or Isochrysis galbana are specific for the conversion of ω-3- or ω-6 fatty acids. Thus, the co
expression of a Δ-9 elongase and a C20-specific Δ-8-desaturase leads to the formation of eicosatrienoic acid (C20:6n-
3, Δ8, 11, 14) and eicosatetraenoic acid (C20:3n-4, Δ8, 11, 14, 17). Co-expression of a third gene coding for a C20-Δ5
specific desaturase leads to the production of Arachidonic acid (C20:6n-4, Δ5, 8, 11, 14) or Eicosapentaenoic acid
(C20:3n-5, Δ5, 8, 11, 14, 17).
[0035] The invention discloses the nucleotide sequence SEQ ID, No: 1 and the polypeptide sequence SEQ ID No: 2.
Derivative(s) of the sequences according to the invention are for example, functional homologues of the polypeptides
or enzymes encoded by SEQ ID NO: 2, but are not part of the invention. Also disclosed are derivatives of SEQ ID NO:
4, SEQ ID NO: 6, SEQ ID NO: 8 or SEQ ID NO: 10 which exhibit the same said specific enzymatic activity, but are not
part of the invention. This specific enzymatic activity allows advantageously the synthesis of unsaturated fatty acids
having more than three double bonds in the fatty acid molecule. By unsaturated fatty acids is meant in what follows
diunsaturated or polyunsaturated fatty acids which possess double bonds. The double bonds may be conjugated or non
conjugated. The said sequences encode enzymes which exhibit Δ-9 elongase, Δ-8-desaturase or -Δ5-desaturase activity.
[0036] The enzymes, Δ-9 elongase, Δ-8-desaturase or - Δ5-desaturase, advantageously either elongates fatty acid
chains with 18 carbon atoms (see SEQ ID NO: 2) or introduces a double bond into fatty acid residues of glycerolipids,
free fatty acids or acyl-CoA fatty acids at position C8-C9 (see SEQ ID NO: 4) or at position C5-C6 (see SEQ ID NO: 6,
SEQ ID NO: 8 or SEQ ID NO: 10).
[0037] The nucleic acid sequence(s) according to the invention (for purposes of the application the singular encom-
passes the plural and vice versa) or fragments thereof may advantageously be used for isolating other genomic sequences
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via homology screening.
[0038] Allele variants include in particular functional variants obtainable by deletion, insertion or substitution of nucle-
otides in the sequences depicted in SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7 or SEQ ID NO: 9 the
enzymatic activity of the derived synthesized proteins being retained.
[0039] Starting from the DNA sequence described in SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7 or
SEQ ID NO: 9 or parts of said sequences such DNA sequences can be isolated using, for example, normal hybridization
methods or the PCR technique from other eukaryotes such as those identified above for example. These DNA sequences
hybridize under standard conditions with the said sequences. For hybridization use is advantageously made of short
oligonucleotides of the conserved regions of an average length of about 15 to 70 bp, preferably of about 17 to 60 bp,
more preferably of about 19 to 50 bp, most preferably of about 20 to 40 bp, for example, which can be determined by
comparisons with other desaturase or elongase genes in the manner known to those skilled in the art. The histidine box
sequences are advantageously employed. However, longer fragments of the nucleic acids according to the invention
or the complete sequences may also be used for hybridization. Depending on the nucleic acid employed: oligonucleotide,
longer fragment or complete sequence, or depending on which type of nucleic acid, DNA or RNA, is used for hybridization
these standard conditions vary. Thus, for example, the melting temperatures of DNA:DNA hybrids are approximately
10 °C lower than those of DNA:RNA hybrids of the same length.
[0040] By standard conditions is meant, for example, depending on the nucleic acid in question temperatures between
42 °C and 58 °C in an aqueous buffer solution having a concentration of between 0.1 and 5 x SSC (1 X SSC = 0.15 M
NaCl, 15 mM sodium citrate, pH 7.2) or additionally in the presence of 50 % formamide, such as by way of example 42
°C in 5 x SSC, 50 % formamide. Hybridization conditions for DNA:DNA hybrids are advantageously 0.1 x SSC and
temperatures between approximately 20 °C and 45 °C, preferably between approximately 30 °C and 45 °C. For DNA:RNA
hybrids the hybridization conditions are advantageously 0.1 x SSC and temperatures between approximately 30 °C and
55 °C, preferably between approximately 45 °C and 55 °C. These specified temperatures for hybridization are melting
temperature values calculated by way of example for a nucleic acid having a length of approximately 100 nucleotides
and a G + C content of 50 % in the absence of formamide. The experimental conditions for DNA hybridization are
described in relevant genetics textbooks such as by way of example Sambrook et al., "Molecular Cloning", Cold Spring
Harbor Laboratory, 1989, and may be calculated by formulae known to those skilled in the art, for example as a function
of the length of the nucleic acids, the nature of the hybrids or the G + C content. Those skilled in the art may draw on
the following textbooks for further information on hybridization: Ausubel et al. (eds), 1985, Current Protocols in Molecular
Biology, John Wiley & Sons, New York; Hames and Higgins (eds), 1985, Nucleic Acids Hybridization: A Practical Ap-
proach, IRL Press at Oxford University Press, Oxford; Brown (ed), 1991, Essential Molecular Biology: A Practical Ap-
proach, IRL Press at Oxford University Press, Oxford.
[0041] By homologues of the sequences SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7 and SEQ ID
NO: 9 is meant derivatives such as by way of example promoter variants. These variants may be modified by one or
more nucleotide exchanges, by insertion(s) and/or deletion(s) without, however, adversely affecting the functionality or
efficiency of the promoters. Furthermore, the promoters can have their efficiency increased by altering their sequence
or be completely replaced by more effective promoters even of foreign organisms.
[0042] By derivatives is advantageously meant variants whose nucleotide sequence has been altered in the region
from -1 to -2000 ahead of the start codon in such a way that the gene expression and/or the protein expression is
modified, preferably increased. Furthermore, by derivatives is also meant variants which have been modified at the 3’ end.
[0043] The nucleic acid sequences according to the invention which encode a Δ-8-desaturase, a Δ-5-desaturase and/or
a Δ-9-elongase may be produced by synthesis or obtained naturally or contain a mixture of synthetic and natural DNA
components as well as consist of various heterologous Δ-8-desaturase, Δ-5-desaturase and/or Δ-9-elongase gene seg-
ments from different organisms. In general, synthetic nucleotide sequences are produced with codons which are preferred
by the corresponding host organisms, plants for example. This usually results in optimum expression of the heterologous
gene. These codons preferred by plants may be determined from codons having the highest protein frequency which
are expressed in most of the plant species of interest. An example concerning Corynebacterium glutamicum is provided
in Wada et al. (1992) Nucleic Acids Res. 20:2111-2118). Such experiments can be carried out using standard methods
and are known to the person skilled in the art.
[0044] In addition, artificial DNA sequences are suitable, provided, as described above, they mediate the desired
property, for example an increase in the content of Δ-8 and/or Δ-5 double bonds in fatty acids, oils or lipids in organisms
such as in a plant by over-expression of the Δ-8-and/or Δ-5-desaturase gene in preferably in crop plants. Such artificial
DNA sequences can exhibit Δ-8 and/or Δ-5-desaturase and/or Δ-9-elongase activity, for example by back-translation of
proteins constructed by means of molecular modeling, or be determined by in vitro selection. Possible techniques for in
vitro evolution of DNA to modify or improve the DNA sequences are described in Patten, P.A. et al., Current Opinion in
Biotechnology 8, 724-733(1997) or in Moore, J.C. et al., Journal of Molecular Biology 272, 336-347 (1997). Particularly
suitable are encoding DNA sequences which are obtained by back-translation of a polypeptide sequence in accordance
with the codon use specific to the host plant. Those skilled in the art familiar with the methods of plant genetics can
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easily determine the specific codon use by computer analyses of other known genes of the plant to be transformed.
[0045] Other suitable equivalent nucleic acid sequences which may be mentioned are sequences that encode fusion
proteins, a component of the fusion protein being a Δ-8-and/or a Δ-5-desaturase polypeptide and/or a Δ-9 elongase
polypeptide or a functionally equivalent part thereof. The second part of the fusion protein can be, for example, another
polypeptide having enzymatic activity or an antigenic polypeptide sequence by means of which it is possible to demon-
strate Δ-8- and/or Δ-5-desaturase or Δ-9-elongase expression (e.g. myc tag or his tag). Preferably, however, this is a
regulatory protein sequence, such as by way of example a signal sequence for the endoplasmic reticulum (= ER) which
directs the Δ-8- and/or Δ-5-desaturase protein and/or the Δ-9-elongase protein to the desired point of action, or regulatory
sequences which influence the expression of the nucleic acid sequence according to the invention, such as promoters
or terminators. In another preferred embodiment the second part of the fusion protein is a plastidial targeting sequence
as described by Napier J.A. [Targeting of foreign proteins to the chloroplast, Methods Mol. Biol., 49, 1995: 369 - 376].
A preferred used vector comprising said plastidial targeting sequence is disclosed by Colin Lazarus [Guerineau F.,
Woolston S., Brooks L., Mullineaux P. "An expression cassette for targeting foreign proteins into chloroplast; Nucleic.
Acids Res., Dec 9, 16 (23), 1988: 11380].
[0046] Advantageously, the Δ-8-desaturase and Δ-9-elongase and/or the Δ-5-desaturase genes in the method ac-
cording to the invention may be combined with other genes for fatty acid biosynthesis. Examples of such genes are the
acyl transferases, other desaturases or elongases such as Δ-4-, Δ-5- or Δ-6-desaturases or w-3- and/or ω-6-specific
desaturases such as Δ-12 (for C18 fatty acids), Δ-15 (for C18 fatty acids) or Δ-19 (for C22 fatty acids) and/or such as Δ-
5- or Δ-6-elongases. For in vivo and especially in vitro synthesis combination with e.g. NADH cytochrome B5 reductases
which can take up or release reduction equivalents is advantageous.
[0047] By the amino acid sequences according to the invention is meant proteins which contain an amino acid sequence
depicted in the sequence SEQ ID NO: 2. Also disclosed are the sequences SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO:
8 and SEQ ID NO: 10. For the estimation of an enzymatic activity which is "not substantially reduced" or which has the
"same enzymatic activity" the enzymatic activity of the derived sequences are determined and compared with the wild
type enzyme activities. In doing this, for example, certain amino acids may be replaced by others having similar physi-
cochemical properties (space filling, basicity, hydrophobicity, etc.). For example, arginine residues are exchanged for
lysine residues, valine residues for isoleucine residues or aspartic acid residues for glutamic acid residues. However,
one or more amino acids may also be swapped in sequence, added or removed, or a plurality of these measures may
be combined with one another. The present invention also encompasses those nucleotide sequences which are obtained
by modification of the Δ-8-desaturase nucleotide sequence, the Δ-5-desaturase nucleotide sequence and/or the Δ-9-
elongase nucleotide sequence used in the inventive processes. The aim of such a modification may be, e.g., to further
bound the encoding sequence contained therein or also, e.g., to insert further restriction enzyme interfaces.
[0048] Functional equivalents also include those variants whose function by comparison as described above with the
initial gene or gene fragment is weakened (= not substantially reduced) or reinforced (= enzyme activity higher than the
activity of the initial enzyme, that is activity is higher than 100 %, preferably higher than 110 %, particularly preferably
higher than 130 %).
[0049] At the same time the nucleic acid sequence may, for example, advantageously be a DNA or cDNA sequence.
Suitable encoding sequences for insertion into an expression cassette according to the invention include by way of
example those which encode a Δ-8-desaturase, a Δ-5-desaturase and/or a Δ-9-elongase with the sequences described
above and lend the host the ability to overproduce fatty acids, oils or lipids having double bonds in the Δ-8-position and
Δ-5-position, it being advantageous when at the same time fatty acids having at least four double bonds are produced.
These sequences may be of homologous or heterologous origin.
[0050] By the expression cassette (= nucleic acid construct or fragment or gene construct) according to the invention
is meant the sequences specified in SEQ ID NO: 1. Also disclosed are expression cassette with SEQ ID NO: 3, SEQ
ID NO: 5, SEQ ID NO: 7 and/or SEQ ID NO: 9 which result from the genetic code and/or derivatives thereof which are
functionally linked with one or more regulation signals advantageously to increase the gene expression and which control
the expression of the encoding sequence in the host cell. These regulatory sequences should allow the selective ex-
pression of the genes and the protein expression. Depending on the host organism this may mean, for example, that
the gene is expressed and/or overexpressed only after induction or that it is expressed and/or overexpressed immediately.
Examples of these regulatory sequences are sequences to which inductors or repressors bind and in this way regulate
the expression of the nucleic acid. In addition to these new regulation sequences or instead of these sequences the
natural regulation of these sequences ahead of the actual structural genes may still be present and optionally have been
genetically modified so that natural regulation was switched off and the expression of the genes increased. However,
the gene construct can also be built up more simply, that is no additional regulation signals have been inserted ahead
of the nucleic acid sequence or derivatives thereof and the natural promoter with its regulation has not been removed.
Instead of this the natural regulation sequence was mutated in such a way that no further regulation ensues and/or the
gene expression is heightened. These modified promoters in the form of part sequences (= promoter containing parts
of the nucleic acid sequences according to the invention) can also be brought on their own ahead of the natural gene
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to increase the activity. In addition, the gene construct may advantageously also contain one or more so-called enhancer
sequences functionally linked to the promoter which allow enhanced expression of the nucleic acid sequence. At the 3’
end of the DNA sequences additional advantageous sequences may also be inserted, such as further regulatory elements
or terminators. The Δ-8- and/or Δ-5-desaturase gene and/or the Δ-9-elongase gene may be present in one or more
copies in the expression cassette (= gene construct).
[0051] As described above, the regulatory sequences or factors can preferably positively influence and so increase
the gene expression of the introduced genes. Thus, reinforcement of the regulatory elements advantageously on the
transcription level may be effected by using powerful transcription signals such as promoters and/or enhancers. However,
in addition reinforcement of translation is also possible, for example by improving the stability of the mRNA.
[0052] Suitable promoters in the expression cassette are in principle all promoters which can control the expression
of foreign genes in organisms such as microorganisms like protozoa such as ciliates, algae such as green, brown, red
or blue algae such as Euglenia, bacteria such as gram-positive or gram-negative bacteria, yeasts such as Saccharo-
myces, Pichia or Schizosaccharomyces or fungi such as Mortierella, Thraustochytrium or Schizochytrium or plants such
as Aleuritia, advantageously in plants or fungi. Use is preferably made in particular of plant promoters or promoters
derived from a plant virus. Advantageous regulation sequences for the method according to the invention are found for
example in promoters such as cos, tac, trp, tet, trp-tet, Ipp, lac, Ipp-lac, laclq-, T7, T5, T3, gal, trc, ara, SP6, λ-PR or in
λ-PL promoters which are employed advantageously in gram-negative bacteria. Other advantageous regulation se-
quences are found, for example, in the gram-positive promoters amy and SPO2, in the yeast or fungal promoters ADC1,
MFα, AC, P-60, CYC1, GAPDH, TEF, rp28, ADH or in the plant promoters CaMV/35S [Franck et al., Cell 21(1980)
285-294], SSU, OCS, lib4, STLS1, B33, nos (= Nopalin Synthase Promoter) or in the ubiquintin or phaseolin promoter.
The expression cassette may also contain a chemically inducible promoter by means of which the expression of the
exogenous Δ8- and/or Δ-5-desaturase gene and/or the Δ-9-elongase gene in the organisms can be controlled advan-
tageously in the plants at a particular time. Advantageous plant promoters of this type are by way of example the PRP1
promoter [Ward et al., Plant. Mol. Biol.22(1993), 361-366], a promoter inducible by benzenesulfonamide (EP 388 186),
a promoter inducible by tetracycline [Gatz et al., (1992) Plant J. 2,397-404], a promoter inducible by salicylic acid (WO
95/19443), a promoter inducible by abscisic acid (EP 335 528) and a promoter inducible by ethanol or cyclohexanone
(WO93/21334). Other examples of plant promoters which can advantageously be used are the promoter of cytosolic
FBPase from potato, the ST-LSI promoter from potato (Stockhaus et al., EMBO J. 8 (1989) 2445-245), the promoter of
phosphoribosyl pyrophosphate amidotransferase from Glycine max (see also gene bank accession number U87999)
or a nodiene-specific promoter as described in EP 249 676. Particularly advantageous are those plant promoters which
ensure expression in tissues or plant parts/organs in which fatty acid biosynthesis or the precursor stages thereof occurs,
as in endosperm or in the developing embryo for example. Particularly noteworthy are advantageous promoters which
ensure seed-specific expression such as by way of example the USP promoter or derivatives thereof, the LEB4 promoter,
the phaseolin promoter or the napin promoter. The particularly advantageous USP promoter cited according to the
invention or its derivatives mediate very early gene expression in seed development [Baeumlein et al., Mol Gen Genet,
1991, 225 (3): 459-67]. Other advantageous seed-specific promoters which may be used for monocotylodonous or
dicotylodonous plants are the promoters suitable for dicotylodons such as napin gene promoters, likewise cited by way
of example, from oilseed rape (US 5,608,152), the oleosin promoter from Arabidopsis (WO 98/45461), the phaseolin
promoter from Phaseolus vulgaris (US 5,504,200), the Bce4 promoter from Brassica (WO 91/13980) or the leguminous
B4 promoter (LeB4, Baeumlein et al., Plant J., 2, 2, 1992: 233-239) or promoters suitable for monocotylodons such as
the promoters of the Ipt2 or Ipt1 gene in barley (WO 95/15389 and WO 95/23230) or the promoters of the barley hordeine
gene, the rice glutelin gene, the rice oryzin gene, the rice prolamin gene, the wheat gliadin gene, the white glutelin gene,
the corn zein gene, the oats glutelin gene, the sorghum kasirin gene or the rye secalin gene which are described in
WO99/16890.
[0053] Furthermore, particularly preferred are those promoters which ensure the expression in tissues or plant parts
in which, for example, the biosynthesis of fatty acids, oils and lipids or the precursor stages thereof takes place. Particularly
noteworthy are promoters which ensure a seed-specific expression. Noteworthy are the promoter of the napin gene
from oilseed rape (US 5,608,152), the USP promoter from Vicia faba (USP = unknown seed protein, Baeumlein et al.,
Mol Gen Genet, 1991, 225 (3): 459-67), the promoter of the oleosin gene from Arabidopsis (WO98/45461), the phaseolin
promoter (US 5,504,200) or the promoter of the legumin B4 gene (LeB4; Baeumlein et al., 1992, Plant Journal, 2 (2):
233-9). Other promoters to be mentioned are that of the Ipt2 or Ipt1 gene from barley (WO95/15389 and WO95/23230)
which mediate seed-specific expression in monocotyledonous plants. Other advantageous seed specific promoters are
promoters such as the promoters from rice, corn or wheat disclosed in WO 99/16890 or Amy32b, Amy6-6 or aleurain
(US 5,677,474), Bce4 (rape, US 5,530,149), glycinin (soy bean, EP 571 741), phosphoenol pyruvat carboxyl-ase (soy
bean, JP 06/62870), ADR12-2 (soy bean, WO 98/08962), isocitratlyase (rape, US 5,689,040) or β-amylase (barley, EP
781 849).
[0054] As described above, the expression construct (= gene construct, nucleic acid construct) may contain yet other
genes which are to be introduced into the organisms. These genes can be subject to separate regulation or be subject
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to the same regulation region as the Δ-8- and/or Δ-5-desaturase gene and/or the Δ-9-elongase gene. These genes are
by way of example other biosynthesis genes, advantageously for fatty acid biosynthesis, which allow increased synthesis.
Examples which may be mentioned are the genes form Δ-15- Δ-12-, Δ-9-, Δ-5-, Δ-4-desaturase, α-ketoacyl reductases,
α-ketoacyl synthases, elongases or the various hydroxylases and acyl-ACP thioesterases. The desaturase genes are
advantageously used in the nucleic acid construct.
[0055] In principle all natural promoters with their regulation sequences can be used like those named above for the
expression cassette according to the invention and the method according to the invention. Over and above this, synthetic
promoters may also advantageously be used.
[0056] In the preparation of an expression cassette various DNA fragments can be manipulated in order to obtain a
nucleotide sequence which usefully reads in the correct direction and is equipped with a correct reading raster. To
connect the DNA fragments (= nucleic acids according to the invention) to one another adaptors or linkers may be
attached to the fragments.
[0057] The promoter and the terminator regions can usefully be provided in the transcription direction with a linker or
polylinker containing one or more restriction points for the insertion of this sequence. Generally, the linker has 1 to 10,
mostly 1 to 8, preferably 2 to 6, restriction points. In general the size of the linker inside the regulatory region is less than
100 bp, frequently less than 60 bp, but at least 5 bp. The promoter may be both native or homologous as well as foreign
or heterologous to the host organism, for example to the host plant. In the 5’-3’ transcription direction the expression
cassette contains the promoter, a DNA sequence which encodes a Δ-8-desaturase gene, a Δ-5-desaturase gene and/or
a Δ-9-elongase gene and a region for transcription termination. Different termination regions can be exchanged for one
another in any desired fashion.
[0058] Furthermore, manipulations which provide suitable restriction interfaces or which remove excess DNA or re-
striction interfaces can be employed. Where insertions, deletions or substitutions, such as transitions and transversions,
come into consideration, in vitro mutagenesis, primer repair, restriction or ligation may be used. In suitable manipulations
such as restriction, chewing back or filling of overhangs for blunt ends complementary ends of the fragments can be
provided for the ligation.
[0059] For an advantageous high expression the attachment of the specific ER retention signal SEKDEL inter alia can
be of importance (Schouten, A. et al., Plant Mol. Biol. 30 (1996), 781-792). In this way the average expression level is
tripled or even quadrupled. Other retention signals which occur naturally in plant and animal proteins located in the ER
may also be employed for the construction of the cassette. In another preferred embodiment a plastidial targeting
sequence is used as described by Napier J.A. [Targeting of foreign proteins to the chloroplast, Methods Mol. Biol., 49,
1995: 369-376]. A preferred used vector comprising said plastidial targeting sequence is disclosed by Colin Lazarus
[Guerineau F., Woolston S., Brooks L., Mullineaux P. "An expression cassette for targeting foreign proteins into chloro-
plast; Nucleic. Acids Res., Dec 9, 16 (23), 1988: 11380].
[0060] Preferred polyadenylation signals are plant polyadenylation signals, preferably those which substantially cor-
respond to T-DNA polyadenylation signals from Agrobacterium tumefaciens, in particular gene 3 of the T-DNA (octopin
synthase) of the Ti plasmid pTiACH5 (Gielen et al., EMBO J.3 (1984), 835 et seq.) or corresponding functional equivalents.
[0061] An expression cassette is produced by fusion of a suitable promoter with a suitable Δ-8- and/or Δ-5-desaturase
DNA sequence and/or a suitable Δ-9-elongase DNA sequence together with a polyadenylation signal by common re-
combination and cloning techniques as described, for example, in T. Maniatis, E.F. Fritsch and J. Sambrook, Molecular
Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) as well as in T.J. Silhavy,
M.L. Berman and L.W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor,
NY (1984) and in Ausubel, F.M. et al., Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-
Interscience (1987).
[0062] In the preparation of an expression cassette various DNA fragments can be manipulated to produce a nucleotide
sequence which usefully reads in the correct direction and is equipped with a correct reading raster. Adapters or linkers
can be attached to the fragments for joining the DNA fragments.
[0063] The promoter and the terminator regions can usefully be provided in the transcription direction with a linker or
polylinker containing one or more restriction points for the insertion of this sequence. Generally, the linker has 1 to 10,
mostly 1 to 8, preferably 2 to 6, restriction points. In general the size of the linker inside the regulatory region is less than
100 bp, frequently less than 60 bp, but at least 5 bp. The promoter may be both native or homologous as well as foreign
or heterologous to the host organism, for example to the host plant. In the 5’-3’ transcription direction the expression
cassette contains the promoter, a DNA sequence which either encodes a Δ-8- and/or Δ-5-desaturase gene and/or a Δ-
9-elongase gene and a region for transcription termination. Different termination regions can be exchanged for one
another in any desired fashion.
[0064] In the preparation of an expression cassette various DNA fragments can be manipulated to produce a nucleotide
sequence which usefully reads in the correct direction and is equipped with a correct reading raster. Adapters or linkers
can be attached to the fragments for joining the DNA fragments.
[0065] The DNA sequences encoding the nucleic acid sequences used in the inventive processes such as the Δ-8-
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desaturase from Euglenia gracilis, the Δ-9-elongase from Isochrysis galbana and/or the Δ-5-desaturase for example
from Caenorhabditis elegans, Mortierella alpina, Borage officinalis or Physcomitrella patens contain all the sequence
characteristics needed to achieve correct localization of the site of fatty acid, lipid or oil biosynthesis. Accordingly, no
further targeting sequences are needed per se. However, such a localization may be desirable and advantageous and
hence artificially modified or reinforced so that such fusion constructs are also a preferred advantageous embodiment
of the invention.
[0066] Particularly preferred are sequences which ensure targeting in plastids. Under certain circumstances targeting
into other compartments (reported in: Kermode, Crit. Rev. Plant Sci. 15, 4 (1996), 285-423) may also be desirable, e.g.
into vacuoles, the mitochondrium, the endoplasmic reticulum (ER), peroxisomes, lipid structures or due to lack of cor-
responding operative sequences retention in the compartment of origin, the cytosol.
[0067] Advantageously, the nucleic acid sequences according to the invention or the gene construct together with at
least one reporter gene are cloned into an expression cassette which is introduced into the organism via a vector or
directly into the genome. This reporter gene should allow easy detection via a growth, fluorescence, chemical, biolumi-
nescence or resistance assay or via a photometric measurement. Examples of reporter genes which may be mentioned
are antibiotic- or herbicide-resistance genes, hydrolase genes, fluorescence protein genes, bioluminescence genes,
sugar or nucleotide metabolic genes or biosynthesis genes such as the Ura3 gene, the IIv2 gene, the luciferase gene,
the β-galactosidase gene, the gfp gene, the 2-desoxyglucose-6-phosphate phosphatase gene, the β-glucuronidase
gene, β-lactamase gene, the neomycin phosphotransferase gene, the hygromycin phosphotransferase gene or the
BASTA (= gluphosinate-resistance) gene. These genes permit easy measurement and quantification of the transcription
activity and hence of the expression of the genes. In this way genome positions may be identified which exhibit differing
productivity.
[0068] In a preferred embodiment an expression cassette comprises upstream, i.e. at the 5’ end of the encoding
sequence, a promoter and downstream, i.e. at the 3’ end, a polyadenylation signal and optionally other regulatory
elements which are operably linked to the intervening encoding sequence for Δ-8-desaturase, Δ-9-elongase and/or Δ-
5-desaturase DNA sequence. By an operable linkage is meant the sequential arrangement of promoter, encoding se-
quence, terminator and optionally other regulatory elements in such a way that each of the regulatory elements can fulfill
its function in the expression of the encoding sequence in due manner. The sequences preferred for operable linkage
are targeting sequences for ensuring subcellular localization in plastids. However, targeting sequences for ensuring
subcellular localization in the mitochondrium, in the endoplasmic reticulum (= ER), in the nucleus, in oil corpuscles or
other compartments may also be employed as well as translation promoters such as the 5’ lead sequence in tobacco
mosaic virus (Gallie et al., Nucl. Acids Res. 15 (1987), 8693 -8711).
[0069] An expression cassette may, for example, contain a constitutive promoter or a tissue-specific promoter (pref-
erably the USP or napin promoter) the gene to be expressed and the ER retention signal. For the ER retention signal
the KDEL amino acid sequence (lysine, aspartic acid, glutamic acid, leucine) or the KKX amino acid sequence (lysine-
lysine-X-stop, wherein X means every other known amino acid) is preferably employed.
[0070] For expression in a prokaryotic or eukaryotic host organism, for example a microorganism such as a fungus
or a plant the expression cassette is advantageously inserted into a vector such as by way of example a plasmid, a
phage or other DNA which allows optimum expression of the genes in the host organism. Examples of suitable plasmids
are: in E. coli pLG338, pACYC184, pBR series such as e.g. pBR322, pUC series such as pUC18 or pUC19, M113mp
series, pKC30, pRep4, pHS1, pHS2, pPLc236, pMBL24, pLG200, pUR290, pIN-III113-B1, λgt11 or pBdCl; in Strepto-
myces pIJ101, pIJ364, pIJ702 or pIJ361; in Bacillus pUB110, pC194 or pBD214; in Corynebacterium pSA77 or pAJ667;
in fungi pALS1, pIL2 or pBB116; other advantageous fungal vectors are described by Romanos, M.A. et al., [(1992)
"Foreign gene expression in yeast: a review", Yeast 8: 423-488] and by van den Hondel, C.A.M.J.J. et al. [(1991) "Hetero-
logous gene expression in filamentous fungi" as well as in More Gene Manipulations in Fungi [J.W. Bennet & L.L. Lasure,
eds., pp. 396-428: Academic Press: San Diego] and in "Gene transfer systems and vector development for filamentous
fungi" [van den Hondel, C.A.M.J.J. & Punt, P.J. (1991) in: Applied Molecular Genetics of Fungi, Peberdy, J.F. et al.,
eds., pp. 1-28, Cambridge University Press: Cambridge]. Examples of advantageous yeast promoters are 2mM, pAG-
1, YEp6, YEp13 or pEMBLYe23. Examples of algal or plant promoters are pLGV23, pGHlac+, pBIN19, pAK2004, pVKH
or pDH51 (see Schmidt, R. and Willmitzer, L., 1988). The vectors identified above or derivatives of the vectors identified
above are a small selection of the possible plasmids. Further plasmids are well known to those skilled in the art and
may be found, for example, in the book Cloning Vectors (Eds. Pouwels P.H. et al. Elsevier, Amster-dam-New York-
Oxford, 1985 , ISBN 0 444 904018). Suitable plant vectors are described inter alia in "Methods in Plant Molecular Biology
and Biotechnology" (CRC Press), Ch. 6/7, pp. 71-119. Advantageous vectors are known as shuttle vectors or binary
vectors which replicate in E. coli and Agrobacterium.
[0071] By vectors is meant with the exception of plasmids all other vectors known to those skilled in the art such as
by way of example phages, viruses such as SV40, CMV, baculovirus, adenovirus, transposons, IS elements, phasmids,
phagemids, cosmids, linear or circular DNA. These vectors can be replicated autonomously in the host organism or be
chromosomally replicated, chromosomal replication being preferred.
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[0072] In a further embodiment of the vector the expression cassette according to the invention may also advanta-
geously be introduced into the organisms in the form of a linear DNA and be integrated into the genome of the host
organism by way of heterologous or homologous recombination. This linear DNA may be composed of a linearized
plasmid or only of the expression cassette as vector or the nucleic acid sequences according to the invention.
[0073] In a further advantageous embodiment the nucleic acid sequence according to the invention can also be
introduced into an organism on its own.
[0074] If in addition to the nucleic acid sequence according to the invention further genes are to be introduced into the
organism, all together with a reporter gene in a single vector or each single gene with a reporter gene in a vector in each
case can be introduced into the organism, whereby the different vectors can be introduced simultaneously or successively.
[0075] The vector advantageously contains at least one copy of the nucleic acid sequences according to the invention
and/or the expression cassette (= gene construct) according to the invention.
[0076] By way of example the plant expression cassette can be installed in the pRT transformation vector ((a) Toepfer
et al., 1993, Methods Enzymol., 217: 66-78; (b) Toepfer et al. 1987, Nucl. Acids. Res. 15: 5890 ff.).
[0077] Alternatively, a recombinant vector (= expression vector) can also be transcribed and translated in vitro, e.g.
by using the T7 promoter and the T7 RNA polymerase.
[0078] Expression vectors employed in prokaryotes frequently make use of inducible systems with and without fusion
proteins or fusion oligopeptides, wherein these fusions can ensue in both N-terminal and C-terminal manner or in other
useful domains of a protein. Such fusion vectors usually have the following purposes: i.) to increase the RNA expression
rate; ii.) to increase the achievable protein synthesis rate; iii.) to increase the solubility of the protein; iv.) or to simplify
purification by means of a binding sequence usable for affinity chromatography. Proteolytic cleavage points are also
frequently introduced via fusion proteins which allows cleavage of a portion of the fusion protein and purification. Such
recognition sequences for proteases are recognized, e.g. factor Xa, thrombin and enterokinase.
[0079] Typical advantageous fusion and expression vectors are pGEX [Pharmacia Biotech Inc; Smith, D.B. and John-
son, K.S. (1988) Gene 67: 31-40], pMAL (New England Biolabs, Beverly, MA) and pRIT5 (Pharmacia, Piscataway, NJ)
which contains glutathione S-transferase (GST), maltose binding protein or protein A.
[0080] Other examples of E. coli expression vectors are pTrc [Amann et al., (1988) Gene 69:301-315] and pET vectors
[Studier et al., Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, California
(1990) 60-89; Stratagene, Amsterdam, The Netherlands].
[0081] Other advantageous vectors for use in yeast are pYepSec1 (Baldari, et al., (1987) Embo J. 6:229-234), pMFa
(Kurjan and Herskowitz, (1982) Cell 30:933-943), pJRY88 (Schultz et al., (1987) Gene 54:113-123), and pYES derivatives
(Invitrogen Corporation, San Diego, CA). Vectors for use in filamentous fungi are described in: van den Hondel, C.A.M.J.J.
& Punt, P.J. (1991) "Gene transfer systems and vector development for filamentous fungi", in: Applied Molecular Genetics
of Fungi, J.F. Peberdy, et al., eds., pp. 1-28, Cambridge University Press: Cambridge.
[0082] Alternatively, insect cell expression vectors can also be advantageously utilized, e.g. for expression in Sf 9
cells. These are e.g. the vectors of the pAc series (Smith et al. (1983) Mol. Cell Biol. 3:2156-2165) and the pVL series
(Lucklow and Summers (1989) Virology 170:31-39).
[0083] Furthermore, plant cells or algal cells can advantageously be used for gene expression. Examples of plant
expression vectors may be found in Becker, D., et al. (1992) "New plant binary vectors with selectable markers located
proximal to the left border", Plant Mol. Biol. 20: 1195-1197 or in Bevan, M.W. (1984) "Binary Agrobacterium vectors for
plant transformation", Nucl. Acid. Res. 12: 8711-8721.
[0084] Furthermore, the nucleic acid sequences may also be expressed in mammalian cells, advantageously in non-
human mammalian cells. Examples of corresponding expression vectors are pCDM8 and pMT2PC referred to in: Seed,
B. (1987) Nature 329:840 or Kaufman et al. (1987) EMBO J. 6: 187-195). At the same time promoters preferred for use
are of viral origin, such as by way of example promoters of polyoma, adenovirus 2, cytomegalovirus or simian virus 40.
Other prokaryotic and eukaryotic expression systems are referred to in chapters 16 and 17 of Sambrook et al., Molecular
Cloning: A Laboratory Manual. 2nd, ed., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold
Spring Harbor, NY, 1989.
[0085] The host organism (= transgenic organism) advantageously contains at least one copy of the nucleic acid
according to the invention and/or of the nucleic acid construct according to the invention.
[0086] The introduction of the nucleic acids according to the invention, the expression cassette or the vector into
organisms, plants for example, can in principle be done by all of the methods known to those skilled in the art. The
introduction of the nucleic acid sequences gives rise to recombinant or transgenic organisms.
[0087] In the case of microorganisms, those skilled in the art can find appropriate methods in the textbooks by Sambrook,
J. et al. (1989) Molecular cloning: A laboratory manual, Cold Spring Harbor Laboratory Press, by F.M. Ausubel et al.
(1994) Current protocols in molecular biology, John Wiley and Sons, by D.M. Glover et al., DNA Cloning Vol.1, (1995),
IRL Press (ISBN 019-963476-9), by Kaiser et al. (1994) Methods in Yeast Genetics, Cold Spring Harbor Laboratory
Press or Guthrie et al. Guide to Yeast Genetics and Molecular Biology, Methods in Enzymology, 1994, Academic Press.
[0088] The transfer of foreign genes into the genome of a plant is called transformation. In doing this the methods
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described for the transformation and regeneration of plants from plant tissues or plant cells are utilized for transient or
stable transformation. Suitable methods are protoplast transformation by poly(ethylene glycol)-induced DNA uptake, the
"biolistic" method using the gene cannon - referred to as the particle bombardment method, electroporation, the incubation
of dry embryos in DNA solution, microinjection and gene transfer mediated by Agrobacterium. Said methods are described
by way of example in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and
Utilization, eds. S.D. Kung and R. Wu, Academic Press (1993) 128-143 and in Potrykus Annu. Rev. Plant Physiol. Plant
Molec. Biol. 42 (1991) 205-225). The nucleic acids or the construct to be expressed is preferably cloned into a vector
which is suitable for transforming Agrobacterium tumefaciens, for example pBin19 (Bevan et al., Nucl. Acids Res. 12
(1984) 8711). Agrobacteria transformed by such a vector can then be used in known manner for the transformation of
plants, in particular of crop plants such as by way of example tobacco plants, for example by bathing bruised leaves or
chopped leaves in an agrobacterial solution and then culturing them in suitable media. The transformation of plants by
means of Agrobacterium tumefaciens is described, for example, by Höfgen and Willmitzer in Nucl. Acid Res. (1988) 16,
9877 or is known inter alia from F.F. White, Vectors for Gene Transfer in Higher Plants; in Transgenic Plants, Vol. 1,
Engineering and Utilization, eds. S.D. Kung and R. Wu, Academic Press, 1993, pp. 15-38.
[0089] Agrobacteria transformed by an expression vector according to the invention may likewise be used in known
manner for the transformation of plants such as test plants like Arabidopsis or crop plants such as cereal crops, corn,
oats, rye, barley, wheat, soybean, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potatoes, tobacco, tomatoes,
carrots, paprika, oilseed rape, tapioca, cassava, arrowroot, tagetes, alfalfa, lettuce and the various tree, nut and vine
species, in particular of oil-containing crop plants such as soybean, peanut, castor oil plant, sunflower, com, cotton, flax,
oilseed rape, coconut, oil palm, safflower (Carthamus tinctorius) or cocoa bean, e.g. by bathing bruised leaves or chopped
leaves in an agrobacterial solution and then culturing them in suitable media. For the production of PUFAs, for example
stearidonic acid, eicosapentaenoic acid and docosahexaenoic acid, borage, linseed, sunflower, safflower or Primulaceae
are advantageously suitable. Other suitable organisms for the production of for example γ-linoleic acid, dihomo-γ-linoleic
acid or arachidonic acid are for example linseed, sunflower or safflower.
[0090] The genetically modified plant cells may be regenerated by all of the methods known to those skilled in the art.
Appropriate methods can be found in the publications referred to above by S.D. Kung and R. Wu, Potrykus or Höfgen
and Willmitzer.
[0091] Accordingly, a further aspect of the invention relates to transgenic organisms transformed by at least one nucleic
acid sequence, expression cassette or vector according to the invention as well as cells, cell cultures, tissue, parts -
such as, for example, leaves, roots, etc. in the case of plant organisms - or reproductive material derived from such
organisms. The terms "host organism", "host cell", "recombinant (host) organism" and "transgenic (host) cell" are used
here interchangeably. Of course these terms relate not only to the particular host organism or the particular target cell
but also to the descendants or potential descendants of these organisms or cells. Since, due to mutation or environmental
effects certain modifications may arise in successive generations, these descendants need not necessarily be identical
with the parental cell but nevertheless are still encompassed by the term as used here.
[0092] For the purposes of the invention "transgenic" or "recombinant" means with regard for example to a nucleic
acid sequence, an expression cassette (= gene construct, nucleic acid construct) or a vector containing the nucleic acid
sequence according to the invention or an organism transformed by the nucleic acid sequences, expression cassette
or vector according to the invention all those constructions produced by genetic engineering methods in which either
a) the nucleic acid sequence depicted in SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 9 or
b) a genetic control sequence functionally linked to the nucleic acid sequence described under (a), for example a
3’- and/or 5’- genetic control sequence such as a promoter or terminator, or
c) (a) and (b)
are not found in their natural, genetic environment or have been modified by genetic engineering methods, wherein the
modification may by way of example be a substitution, addition, deletion, inversion or insertion of one or more nucleotide
residues. Natural genetic environment means the natural genomic or chromosomal locus in the organism of origin or
inside the host organism or presence in a genomic library. In the case of a genomic library the natural genetic environment
of the nucleic acid sequence is preferably retained at least in part. The environment borders the nucleic acid sequence
at least on one side and has a sequence length of at least 50 bp, preferably at least 500 bp, particularly preferably at
least 1,000 bp, most particularly preferably at least 5,000 bp. A naturally occurring expression cassette - for example
the naturally occurring combination of the natural promoter of the nucleic acid sequence according to the invention with
the corresponding Δ-8-desaturase, Δ-9-elongase and/or Δ-5-desaturase gene - turns into a transgenic expression cas-
sette when the latter is modified by unnatural, synthetic ("artificial") methods such as by way of example a mutagenation.
Appropriate methods are described by way of example in US 5,565,350 or WO 00/15815.
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[0093] Suitable organisms or host organisms for the nucleic acid, expression cassette or vector according to the
invention are advantageously in principle all organisms which are able to synthesize fatty acids, especially unsaturated
fatty acids or are suitable for the expression of recombinant genes as described above. Further examples which may
be mentioned are plants such as Arabidopsis, Asteraceae such as Calendula or crop plants such as soybean, peanut,
castor oil plant, sunflower, corn, cotton, flax, oilseed rape, coconut, oil palm, safflower (Carthamus tinctorius) or cocoa
bean. Preference is given to organisms which can naturally synthesize oils in relatively large quantities such as plants
such as soybean, oilseed rape, coconut, oil palm, safflower, flax, castor oil plant, Calendula, peanut, cocoa bean or
sunflower, and particular preference is given to soybean, flax, oilseed rape, sunflower or Calendula.
[0094] Further useful host cells are identified in: Goeddel, Gene Expression Technology: Methods in Enzymology 185,
Academic Press, San Diego, CA (1990).
[0095] Usable expression strains, e.g. those exhibiting a relatively low protease activity, are described in: Gottesman,
S., Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, California (1990) 119-128.
[0096] A further object of the invention relates to the use of an expression cassette containing DNA sequences encoding
a Δ-8-desaturase, a Δ-9-elongase and/or a Δ-5-desaturase gene or DNA sequences hybridizing therewith for the trans-
formation of plant cells, tissues or parts of plants. The aim of use is to increase the content of fatty acids, oils or lipids
having an increased content of double bonds.
[0097] In doing so, depending on the choice of promoter, the Δ-8-desaturase, a Δ-9-elongase and/or a Δ-5-desaturase
gene can be expressed specifically in the leaves, in the seeds, the nodules, in roots, in the stem or other parts of the
plant. Those transgenic plants overproducing fatty acids, oils or lipids having at least three double bonds in the fatty acid
molecule, the reproductive material thereof, together with the plant cells, tissues or parts thereof are a further object of
the present invention.
[0098] The expression cassette or the nucleic acid sequences according to the invention containing a Δ-8-desaturase,
a Δ-9-elongase and/or a Δ-5-desaturase gene sequence can, moreover, also be employed for the transformation of the
organisms identified by way of example above such as bacteria, cyanobacteria, yeasts, filamentous fungi, ciliates and
algae with the objective of increasing the content of fatty acids, oils or lipids possessing at least three double bonds.
[0099] Within the framework of the present invention, increasing the content of fatty acids, oils or lipids possessing at
least three double bonds means, for example, the artificially acquired trait of increased biosynthetic performance due
to functional overexpression of the Δ-8-desaturase, Δ-9-elongase and/or Δ-5-desaturase gene in the organisms according
to the invention, advantageously in the transgenic plants according to the invention, by comparison with the nongenetically
modified initial plants at least for the duration of at least one plant generation.
[0100] The preferred locus of biosynthesis, of fatty acids, oils or lipids for example, is generally the seed or cell layers
of the seed so that a seed-specific expression of the Δ-8-desaturase, Δ-9-elongase and/or Δ-5-desaturase gene is
appropriate. It is, however, obvious that the biosynthesis of fatty acids, oils or lipids need not be limited to the seed tissue
but rather can also occur in tissue-specific manner in all other parts of the plant - in epidermis cells or in the nodules for
example.
[0101] A constitutive expression of the exogenous Δ-8-desaturase, Δ-9-elongase and/or Δ-5-desaturase gene is, more-
over, advantageous. On the other hand, however, an inducible expression may also appear desirable.
[0102] The efficiency of the expression of the Δ-8-desaturase, Δ-9-elongase and/or Δ-5-desaturase gene can be
determined, for example, in vitro by shoot meristem propagation. In addition, an expression of the Δ-8-desaturase, Δ-9-
elongase and/or Δ-5-desaturase gene modified in nature and level and its effect on fatty acid, oil or lipid biosynthesis
performance can be tested on test plants in greenhouse trials.
[0103] An additional object of the invention comprises transgenic plants transformed by an expression cassette con-
taining a Δ-8-desaturase, a Δ-9-elongase and/or a Δ-5-desaturase gene sequence according to the invention or DNA
sequences hybridizing therewith, as well as transgenic cells, tissue, parts and reproduction material of such plants.
Particular preference is given in this case to transgenic crop plants such as by way of example barley, wheat, rye, oats,
corn, soybean, rice, cotton, sugar beet, oilseed rape and canola, sunflower, flax, hemp, thistle, potatoes, tobacco,
tomatoes, tapioca, cassava, arrowroot, alfalfa, lettuce and the various tree, nut and vine species.
[0104] For the purposes of the invention plants are mono- and dicotyledonous plants, mosses or algae.
[0105] A further refinement according to the invention are transgenic plants as described above which contain a nucleic
acid sequence according to the invention or a expression cassette according to the invention.
[0106] Also disclosed are:
- A method for the transformation of a plant comprising the introduction of expression cassettes according to the
invention containing a Δ-8-desaturase, a Δ-9-elongase and/or a Δ-5-desaturase gene sequence derived from algae
such as Euglenia or Isochrysis, fungi such as Mortierella or mosses such as Physcomitrella or DNA’ sequences
hybridizing therewith into a plant cell, into callus tissue, an entire plant or protoplasts of plants.
- A method for producing PUFAs, wherein the method comprises the growing of a transgenic organism comprising
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a nucleic acid as described herein or a vector encoding a Δ-8-desaturase, a Δ-9-elongase and/or a Δ-5-desaturase
which specifically synthesize poly unsaturated fatty acids with at least three double bonds in the fatty acid molecule
- Use of a Δ-8-desaturase, a Δ-9-elongase and/or a Δ-5-desaturase DNA gene sequence or DNA sequences hybrid-
izing therewith for the production of plants having an increased content of fatty acids, oils or lipids having at least
three double bonds due to the expression of said Δ-8-desaturase, Δ-9-elongase and/or Δ-5-desaturase DNA se-
quence in plants.
[0107] Also disclosed is a method for producing unsaturated fatty acids comprising: introducing at least one said
nucleic acid sequence described herein or at least one nucleic acid construct or vector containing said nucleic acid
sequence into a preferably oil-producing organism such as a plant or a fungi; growing said organism; isolating oil contained
in said organism; and liberating the fatty acids present in said oil. These unsaturated fatty acids advantageously contain
at least three double bonds in the fatty acid molecule. The fatty acids may be liberated from the oils or lipids, for example
by basic hydrolysis, e.g. using NaOH or KOH or by acid hydrolysis preferably in the presence of an alcohol such as
methanol or ethanol. Said fatty acid liberation leads to free fatty acids or to the corresponding alkyl esters of the fatty
acids. In principle an enzymatic hydrolysis for example with a lipase as enzyme is also possible. Starting from said free
fatty acids or fatty acid alkyl esters mono-, di- and/or triglycerides can be synthesized either chemically or enzymatically.
In another preferred embodiment of the inventive process the alkyl ester of the fatty acids are produced from the oils
and lipids by transesterification with an enzyme of with conventional chemistry. A preferred method is the production of
the alkyl ester in the presence of alcohalates of the corresponding lower alcohols (C1 to C10 alcohols such as methanol,
ethanol, propanol, butanol, hexanol etc.) such as methanolate or ethanolate. Therefore as the skilled worker knows the
alcohol in the presence of a catalytic amount of a base such as NaOH or KOH is added to the oils or lipids.
[0108] A method for producing triglycerides having an increased content of unsaturated fatty acids comprising: intro-
ducing at least one said nucleic acid sequence according to the invention or at least one expression cassette according
to the invention into an oil-producing organism; growing said organism; and isolating oil contained in said organism; is
also numbered among the objects of the invention.
[0109] Also disclosed is a method for producing triglycerides having an increased content of unsaturated fatty acids
advantageously having an increased content of unsaturated fatty acids is a method wherein the fatty acids are liberated
from the triglycerides with the aid of basic hydrolysis known to those skilled in the art or by means of an enzyme such
as a lipase.
[0110] The methods specified above advantageously allow the synthesis of fatty acids or triglycerides having an
increased content of fatty acids containing at least three double bonds in the fatty acid molecule.
[0111] The methods identified above advantageously allow the synthesis of fatty acids or triglycerides having an
increased content of fatty acids containing at least three double bonds, wherein the substrate used for the reaction of
the Δ-8-desaturase, Δ-9-elongase and/or Δ-5-desaturase is preferably - linoleic acid (C20:2Δ9,12) acid and/or α-linolenic
acid (C18:2Δ9,12,15). In this way the method identified above advantageously allows in particular the synthesis of fatty
acids derived from linoleic acid (C20:2Δ9,12), α-linolenic acid (C18:2Δ9,12,15), γ-linoleic acid (C18:3Δ6,9,12), stearidonic acid
(C18:4Δ6, 9, 12, 15), dihomo-γ-linoleic acid (C20:3Δ8,11,14) or such as by way of example eicosapentaenoic acid and arachi-
donic acid.
[0112] Examples of organisms for the said methods as described above are plants such as Arabidopsis, Primulaceae,
borage, barley, wheat, rye, oats, corn, soybean, rise, cotton, sugar beet, oilseed rape and canola, sunflower, flax, hemp,
potatoes, tobacco, tomatoes, rape, tapioca, cassava, arrowroot, alfalfa, peanut, castor oil plant, coconut, oil palm, saf-
flower (Carthamus tinctorius) or cocoa bean, algae or protozoa such as dinoflagellates like Crypthecodinium. Preference
is given to organisms which can naturally synthesize oils in relatively large quantities such as plants such as soybean,
oilseed rape, coconut, oil palm, safflower, castor oil plant, Calendula, peanut, cocoa bean or sunflower, and particular
preference is given to soybean, oilseed rape, sunflower, flax, Primulaceae, borage or Carthamus.
[0113] Depending on the host organism, the organisms used in the methods are grown or cultured in the manner
known to those skilled in the art. Microorganisms such as fungi or algae are usually grown in a liquid medium containing
a carbon source, usually in the form of sugars, a nitrogen source, usually in the form of organic nitrogen sources such
as yeast extract or salts such as ammonium sulfate, trace elements such as iron, manganese or magnesium salts and
optionally vitamins at temperatures of between 10 °C and 60 °C, preferably between 15 °C and 40 °C with exposure to
gaseous oxygen. In doing so the pH of the nutrient liquid may be kept at a fixed value, that is during growth it is or is not
regulated. Growth can ensue in batch mode, semibatch mode or continuously. Nutrients can be provided at the start of
fermentation or be fed in semicontinuously or continuously.
[0114] After transformation plants are first of all regenerated as described above and then cultured or cultivated as
normal.
[0115] After growth the lipids are isolated from the organisms in the usual way. For this purpose, after harvesting the
organisms may first of all be digested or used directly. The lipids are advantageously extracted using suitable solvents
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such as apolar solvents like hexane or ethanol, isopropanol or mixtures such as hexane/isopropanol, phenol/chloro-
form/isoamyl alcohol at temperatures of between 0 °C and 80 °C, preferably between 20 °C and 50 °C. The biomass is
usually extracted with an excess of solvent, for example an excess of solvent to biomass of 1:4. The solvent is then
removed, for example by distillation. Extraction can also be done using supercritical CO2. After extraction the remaining
biomass may be removed, for example by filtration.
[0116] The crude oil isolated in this way can then be further purified, for example by removing cloudiness by treatment
with polar solvents such as acetone or chloroform and then filtration or centrifugation. Further purification through columns
is also possible.
[0117] In order to obtain the free acids from the triglycerides the latter are saponified in the usual way.
[0118] Also disclosed are unsaturated fatty acids and triglycerides having an increased content of unsaturated fatty
acids produced by the methods identified above and use thereof for producing foods, animal feeds, cosmetics or phar-
maceuticals. For this purpose the latter are added in customary quantities to the foods, the animal feed, the cosmetics
or pharmaceuticals.
[0119] Said unsaturated fatty acids as well as triglycerides having an increased content of unsaturated fatty acids
produced by the methods identified above are the result of the expression of the nucleic acids according to the invention
in the various host organisms. This results overall in a modification of the composition of the compounds in the host cell
containing unsaturated fatty acids by comparison with the original starting host cells which do not contain the nucleic
acids. These modifications are more marked in host organisms, for example plant cells, which naturally do not contain
the proteins or enzymes encoded by the nucleic acids than in host organisms which naturally do contain the proteins or
enzymes encoded by the nucleic acids. This gives rise to host organisms containing oils, lipids, phospholipids, sphingo-
lipids, glycolipids, triacylglycerols and/or free fatty acids having a higher content of PUFAs with at least three double
bonds. For the purposes of the invention, by an increased content is meant that the host organisms contain at least 5
%, advantageously at least 10 %, preferably at least 20 %, particularly preferably at least 30 %, most particularly preferably
at least 40 % more polyunsaturated fatty acids by comparison with the initial organism which does not contain the nucleic
acids according to the invention. This is particularly the case for plants which do not naturally contain longer-chain
polyunsaturated C20 or C22 fatty acids such as EPA or ARA. Due to the expression of the nucleic acids novel lipid
compositions are produced by said means these being a further aspect of the invention.
[0120] The invention is explained in more detail by the following examples.
Examples
Example 1: General cloning methods
[0121] The cloning methods, such as by way of example restriction cleavages, agarose gel electrophoresis, purification
of DNA fragments, transfer of nucleic acids to nitrocellulose and nylon membranes, linkage of DNA fragments, trans-
formation of - Escherichia coli cells, culture of bacteria and sequence analysis of recombinant DNA, were carried out as
described in Sambrook et al. (1989) (Cold Spring Harbor Laboratory Press: ISBN 0-87969-309-6).
Example 2: Sequence analysis of recombinant DNA
[0122] Sequencing of recombinant DNA molecules was done using a laser fluorescence DNA sequencer from the ABI
company by the method of Sanger (Sanger et al. (1977) Proc. Natl. Acad. Sci. USA74, 5463-5467). Fragments resulting
from a polymerase chain reaction were sequenced and checked to prevent polymerase errors in the constructs to be
expressed.
Example 3: Cloning of the Δ-8-desaturase from Euglena gracilis (= SEQ ID NO: 1)
[0123] As a template for PCR amplification, cDNA from Euglena gracilis Strain Z was used. The cDNA was synthesised
from total RNA extracted from cultures of E. gracilis strain Z. Unique primers to the initiating methionine and the stop
codon of the Euglena Δ-8-desaturase were synthesized as shown, including restriction sites as detailed
Primer 1: EDELTA8BamF
ATGGATCCACCATGAAGTCAAAGCGCCAA
Primer 2: EDELTA8XhoR
ATCTCGAGTTATAGAGCCTTCCCCGC
PCR protocol
[0124]
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Addition temperature: 1 min at 45 °C
Denaturing temperature: 1 min at 94 °C
Elongation temperature: 2 min at 72 °C
Number of cycles: 30
[0125] The PCR products were separated on an agarose gel and a 1270 bp fragment was isolated. The PCR fragment
was cloned in the pGEM-T easy vector (Promega) and the insert was then sequenced. This revealed the presence of
an open reading frame of 1266 base pairs, encoding a protein of 421 amino acid residues and a stop codon. The C-
terminus of the cloned Δ-8-desaturase has high homologies to the Δ-8-desaturase published by Wallis and Browse
(Archives of Biochem. and Biophysics, Vol. 365, No. 2, 1999) which is reported to be an enzyme of 422 residues; see
also related sequence by these authors [GenBank AF139720/ AAD45877] which purports to relate to the same Δ-8-
desaturase but describes an open reading frame of 419 residues]. The deduced amino acid sequence the Euglena Δ-
8-desaturase described in this present invention differs from that previously described by heterogeneity at the N-terminus.
In particular, the first 25 amino acid residues of LARS Δ-8-desaturase is:
MKSKRQALP LTIDGTTYDVS AWVNF
[0126] Whereas the sequence described by Wallis & Browse is:
MKSKRQALS PLQLMEQTYDV SAWVN (as given in ABB 1999)
[0127] Or, alternatively
MKSKRQALSPLQLMEQTYDVVNFH (as given in GenBank AAD45877)
[0128] Said heterogeneity present at the N-terminus of the desaturase sequence is not resultant of the PCR amplifi-
cation or primers. The distinctions are true differences between the proteins.
Example 4: Construction of transgenic plants expressing the Isochrysis galbana elongase component IgASE1
[0129] The cloning of IgASE1 cDNA is described in: Qi, B., Beaudoin, F., Fraser, T., Stobart, A. K., Napier, J.A. and
Lazarus, C.M.Identification of a cDNA encoding a novel C18-Δ-9-polyunsaturated fatty acid-specific elongating activity
from the docosahexaenoic acid (DHA)-producing microalga, Isochrysis galbana. FEBS Letters 510, 159-165 (2002).
The cDNA was released from plasmid vector pCR2.1-TOPO by digestion with KpnI, and ligated into the KpnI site of the
intermediate vector pBlueBac 4.5 (Invitrogen). Recombinant plasmids were screened for insert orientation with EcoRI.
The insert was released from a selected plasmid with PstI plus EcoRI and ligated into binary vector plasmid pCB302-1
(Xiang et al, 1999) that had been cut with the same enzymes. This placed the IgASE1 coding region under the control
of the CaMV 35S promoter as a translational fusion with the transit peptide of the small subunit of Rubisco (Xiang at al.,
1999), with the intention of targeting the elongase component to chloroplasts when expressed in transgenic plants. This
recombinant binary vector was designated pCB302-1ASE. To construct a similar vector with expression of the elongase
component targeted to the microsomal membrane, the IgASE1 coding region was removed from the intermediate vector
by digestion with BamHI plus Spel, and ligated into the corresponding sites of pCB302-3 (Xiang et al., 1999, in which
the map of pCB302-3 is incorrect: the CaMV 35S promoter (plus omega sequence) and nos terminator regions are
reversed with respect to MCS2). This recombinant binary vector was designated pCB302-3ASE.
Example 5: Plant expression of the elongase
[0130] Binary vectors were transferred to Agrobacterium tumefaciens strain GV3101 by electroporation; transformed
colonies were selected on medium containing 50 mg ml-1 kanamycin. Selected colonies were gown to stationary phase
at 28°C, then the cells were concentrated by centrifugation and resuspended in a dipping solution containing 5% sucrose,
0.03% Silwet-177 and 10 mM MgCl2.
[0131] Seeds of Arabidopsis thaliana ecotype Columbia 4 were germinated on one-half-strength Murashige and Skoog
medium, and seedlings were transferred to compost in 15 cm flower pots. Plants were grown to flowering stage in a
growth cabinet at 21°C, with a 23 light and 1 hour dark cycle. Plant transformation was carried out by the floral dipping
method of Clough and Bent (1998, Floral dip: a simplified method for Agrobacterium-mediated transformation of Arabi-
dopsis thaliana. Plant Journal 16, 735-743 (1998), essentially as follows:
[0132] For each construct two pots containing 16 plants were inverted in the dipping solutions containing transformed
A. tumefaciens (described above). The plants were then covered with a plastic bag and left at room temperature in the
dark overnight. The bag was then removed and the plants transferred to the growth cabinet. Dipping (with fresh A.
tumefaciens solutions) was repeated after 5 days and the plants were allowed to set seed. Bulked seed from dipped
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plants (= T1 seed) was collected, and approximately 10000 seed sprinkled onto compost in a seed tray, and, after
stratification at 4°C for 2 days, cultivated in the growth cabinet. When seedlings had reached the 2 to 4 true-leaf stage
they were sprayed with Liberty herbicide (Aventis, 0.5g glufosinate-ammonium I-1), and spraying was repeated one week
later. Twelve herbicide-resistant plants were selected and potted on for each line (chloroplast or cytoplasm targeted
elongase component), and allowed to self fertilize. Samples of T2 seed collected from these plants were germinated on
one-half-strength Murashige and Skoog medium containing Liberty (5 mg glufosinate-ammonium I-1). T3 seed collected
from individual surviving plants was then again germinated on Liberty plates to screen for lines that had ceased segre-
gating for herbicide resistance. Total fatty acids extracted from leaves of such lines were analysed and those with the
greatest C20 content (CB12-4 with the chloroplast-targeted elongase component and CA1-9 with the cytoplasm-targeted
elongase component) selected.
Example 6: Production of transgenic plants expressing the Isochrysis galbana elongase component IgASE1 and the 
Euglena gracilis Δ8 desaturase EUGD8
[0133] The Δ-8-desaturase coding region was removed from the yeast expression vector pESC-Trp with BamHI plus
XhoI, ligated into the BamHI and XhoI sites of pBlueBac 4.5 (Invitrogen) and transformed into E. coli strain Tam1. The
insert was removed from a recombinant plasmid with Bg/II and BamHI, ligated into the BamHI site of pBECKS19.6 and
transformed into E. coli strain Tam1. DNA minipreparations were made of the recombinant plasmids of 6 transformant
colonies; these were digested with XhoI to determine the orientation of insertion of the desaturase coding region in the
binary vector. One recombinant plasmid with the insert in the correct orientation for expression from the CaMV 35S
promoter was transferred to Agrobacterium tume-faciens strain GV3101 by electroporation and a dipping solution pre-
pared from a transformed colony as described above.
[0134] Arabidopsis thaliana lines CB12-4 and CA1-9 (see above) were subjected to floral dipping as described above.
Approximately 2000 T1-seed from each line were spread on 15 cm petri dishes containing one-half-strength Murashige
and Skoog (solid) medium supplemented with 50 mg ml-1 kanamycin and germinated in the growth cabinet. 12 kanamycin-
resistant plants of the CA1-9 parental line and 3 plants of the CB12-4 parental line were transferred to potting compost
and further cultivated in the growth room. Fatty acid analysis was conducted on a lea taken from each of the T2 plants,
which were allowed to mature and set seed.
References
[0135]
McCormac, A.C., Eliott, M.C. and Chen, D-F.; pBECKS. A flexible series of binary vectors for Agrobacterium-
mediated plant transformation. Molecular Biotechnology 8, 199-213 (1997).
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Example 7: Production of transgenic plants expressing the Isochrysis galbana elongase component IgASE1 and the 
Euglena gracilis Δ8 desaturase EUGD8 and a Δ5 desaturase
[0136] The Δ5 desaturase from Phaeodactylum tricornutum was cloned into the pGPTV plasmid (Becker, D. et al.;
Plant Mol. Biol. 20 (1992), 1195-1197) habouring a hygromycin resistence selectable marker gene. For seed-specific
expression the USP promoter from Vicia faber was cloned 5’-prime to the ATG of the Δ5 desaturase.
[0137] The binary vector was transferred to Agrobacterium tumefaciens strain GV 3101 and transformed colonies
were selected on medium containing 30 mgml-1 hygromycin. Selected Agrobacteria were used for the transformation
(flower transformation) of Arabidopsis plants carrying the T-DNA insertions with the Δ9 elongase and the Δ5 desaturase.
[0138] Arabidopsis thaliana seedlings were germinated on Murashige and Skoog medium containing hygromycin and
resistent plants were transferred to the greenhouse.
[0139] Seeds collected from individual plants were harvested and the total fatty acid profile was analyzed using GC
methods.
Example 8: Cloning of expression plasmids for seed-specific expression in plants
[0140] pBin-USP is a derivative of the plasmid pBin19. pBin-USP was produced from pBin19 by inserting a USP
promoter as an EcoRI-BaMHI fragment into pBin19 (Bevan et al. (1980) Nucl. Acids Res. 12, 8711). The polyadenylation
signal is that of gene 3 of the T-DNA of the Ti plasmid pTiACH5 (Gielen et al., (1984) EMBO J. 3, 835), whereby
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nucleotides 11749-11939 were isolated as a PvuII-HindIII fragment and after addition of Sphl linkers to the Pvull interface
between the SpHI-HindIII interface of the vector were cloned. The USP promoter corresponds to nucleotides 1-684
(gene bank accession number X56240), wherein a part of the nonencoding region of the USP gene is contained in the
promoter. The promoter fragment running to 684 base pairs was amplified by standard methods by means of commercial
T7 standard primer (Stratagene) and using a synthesized primer through a PCR reaction.
Primer sequence:
[0141] The PCR fragment was cut again using EcoRI/SalI and inserted into the vector pBin19 with OCS terminator.
The plasmid having the designation pBinUSP was obtained. The constructs were used for transforming Arabidopsis
thaliana, oilseed rape, tobacco and linseed.
Example 9: Production of transgenic oil crops
[0142] Production of transgenic plants (modified in accordance with Moloney et al., 1992, Plant Cell Reports, 8:238-242)
[0143] To produce transgenic oilseed rape plants binary vectors in Agrobacterium tumefaciens C58C1:pGV2260 or
Escherichia coli were used (Deblaere et al, 1984, Nucl. Acids. Res. 13, 4777-4788). For transforming oilseed rape plants
(var. Drakkar, NPZ Nordeutsche Pflanzenzucht, Hohenlieth, Germany) a 1:50 dilution of an overnight culture of a positively
transformed agrobacteria colony in Murashige-Skoog medium (Murashige and Skoog 1962 Physiol. Plant. 15, 473)
containing 3 % of saccharose (3MS medium) was used. Petioles or hypocotyledons of freshly germinated sterile rape
plants (approx. 1 cm2 each) were incubated in a Petri dish with a 1:50 agrobacteria dilution for 5-10 minutes. This was
followed by 3-day concubation in darkness at 25 °C on 3MS medium containing 0.8 % of Bacto-Agar. After three days,
culturing was continued with 16 hours of light / 8 hours of darkness and in a weekly cycle on MS medium containing
500 mg/l of Claforan (sodium cefotaxime), 50 mg/l of kanamycin, 20 microM of benzylaminopurine (BAP) and 1.6 g/l of
glucose. Growing shoots were transferred onto MS medium containing 2 % of saccharose, 250 mg/l of Claforan and 0.8
% of Bacto-Agar. If after three weeks no roots had formed 2-indolylbutyric acid was added to the medium as a growth
hormone for rooting purposes.
[0144] Regenerated shoots were obtained on 2MS medium using kanamycin and Claforan, transferred into soil after
rooting and after culturing grown for two weeks in a climate-controlled chamber, brought to blossom and after harvesting
of ripe seed investigated for Δ-8-desaturase expression by means of lipid analyses. Lines having increased contents of
double bonds at the Δ-8-position were identified. In the stably transformed transgenic lines functionally expressing the
transgene it was found that there is an increased content of double bonds at the Δ-8-position by comparison with
untransformed control plants.
[0145] The same procedure was done to create plants with Δ-9-elongase and/or Δ-5-desaturase activity.
a) Transgenic flax plants
[0146] Transgenic flax plants may be produced, for example by the by the method Bell et al., 1999, In Vitro Cell. Dev.
Biol.-Plant. 35(6):456-465, by means of particle bombardment. Agrobacteria-mediated transformations can be produced,
for example, as described by Mlynarova et al. (1994), Plant Cell Report 13: 282-285.
Example 10: Lipid extraction from seed and leave material
[0147] Plant material (approx 200 mg) was first of all mechanically homogenized by means of triturators in order to
render it more amenable to extraction.
[0148] The disrupted cell sediment was hydrolyzed with 1 M methanolic hydrochloric acid and 5 % dimethoxypropane
for 1 h at 85 °C and the lipids were transmethylated. The resultant fatty acid methyl esters (FAMEs) were extracted in
hexane. The extracted FAMEs were analyzed by gas-liquid chromatograph using a capillary column (Chrompack, WCOT
fused silica, CP wax 52 CB, 25 m, 0.32 mm) and a temperature gradient of from 170 °C to 240 °C in 20 min and 5 min
at 240 °C. The identity of the fatty acid methyl esters was confirmed by comparison with corresponding FAME standards
(Sigma). The identity and the position of the double bond was further analyzed by means of GC-MS by suitable chemical
derivatization of the FAME mixtures, e.g. to form 4,4-dimethoxyoxazoline derivatives (Christie, 1998).
[0149] Figure 1 shows the fatty acid profile (FAMes) of leaf tissue from wildtype Arabidopsis thaliana as a control.
Figure 2 shows the fatty acid profile (FAMes) of leaf tissue from transgenic Arabidopsis expressing the Isochrysis Δ-9-
elongase (see example 4). This Arabidopsis line was subsequently re-transformed with the Euglena Δ-8-desaturase.
EP 1 576 166 B1
21
5
10
15
20
25
30
35
40
45
50
55
The fatty acid profile (FAMes) of said double transformed Arabidopsis line (Line IsoElo X Eu D8 des) is given in Figure 3.
[0150] Furthermore this double transformed Arabidopsis line (Line IsoElo X Eu D8 des) was subsequently re-trans-
formed with the Mortierella Δ5 desaturase (Mort Δ5) gene. The fatty acid profile (FAMes) of said triple transformed
Arabidopsis line (Line IsoElo X EU D8 des x Mort Δ5) is given in Figure 4.
Example 11: GC profiles of Arabidopsis leaf fatty acid methyl esters from different transgenics
[0151] Figure 5 shows GC profiles of Arabidopsis leaf fatty acid methyl esters extracted from wild type (WT 5a), single
transgenic plants expressing Isochrysis galbana Δ9 elongase gene Ig ASE1 (5b), double transgenic plant expressing
the Ig ASE1 and Euglena Δ8 desaturase (EU Δ8) genes (5c) and the triple transfenic plant expressing the Ig ASE1, Eu
Δ8 and the Mortierella Δ5 desaturase (Mort Δ5) genes (5d).
[0152] All transgenes are under the control of the 35S-CaMV viral promoter. Isochrysis Δ9 elongase (IgASE1) with
SSU Rubisco transit sequence [T-DNA Basta-r] were retransformed with Euglena Δ8-desaturasemut175+313 [T-DNA
Kanamycin-r]. The double transformed line, which is homozygous for both Basta-r and Kanamycin-r, were transformed
again with Mortierella Δ5 desaturase (T-DNA Hygromycin-r). The resulting triple transformed line is homozygous for
both Basta-r and Kanamycin-r, but heterozygous for Hygromycin-r.
SEQUENCE LISTING
[0153]
<110> University of Bristol
Table 1 shows the fatty acid composition of Arabidopsis plants prepared from wild type (Wt), single transgenic plant 
expressing the Isochrysis galbana IgASE1 elongase gene, double transgenic plants expressing the IgASE1 elongase 
gene and the Euglena Δ8 desaturase gene and triple transgenic plants expressing the IgASE1, the Euglena Δ8 and 
the Mortierella Δ5 desaturase gene. Analysis is of leaf tissue from rosette stage Arabidopsis plants. Each value 
represents the average of 2 measurements.
Fatty acid (mol% of 
total)
Plant source
Wt IgASE1 transgenic
IgASE1+EuΔ8 
transgenic
IgASE1+EuΔ8+MortΔ5 
transgenic
16:0 19.9 19.2 14.7 14.2
16:1 2.8 3.3 1.8 2.3
16:3 13.1 12.2 19.9 15.4
18:0 1.7 2.4 0.8 1.5
18:1n-9 1.7 5.1 1.6 3.4
18:2n-6 11.2 9.0 4.2 6.6
18:3n-3 50.1 31.0 36.0 31.2
20:2n-6 - 7.9 0.9 3.2
20:3,Δ5,11,14 - 1.5
20:3n-6 - - 9.1 1.5
20:4n-6 (ARA) - - 6.6
20:3n-3 - 9.9 4.0 4.8
20,4Δ5,11,14,17 - - - 1.6
20:4n-3 - - 7.2 2.9
20:5n-3 (EPA) - - - 3.3
Total C20 PUFAs - 17.8 21.2 22.2
EP 1 576 166 B1
22
5
10
15
20
25
30
35
40
45
50
55
<120> Novel method for the production of polyunsaturated fatty acids
<130> 2002_791
<140> 2002_271
<141> 2202-12-18
<160> 10
<170> PatentIn Ver. 2.0
<210> 1
<211> 1266
<212> DNA
<213> Euglena gracilis
<220>
<221> CDS
<222> (1)..(1266)
<223> delta-8-desaturase
<400> 1
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<210> 2
<211> 421
<212> PRT
<213> Euglena gracilis
<400> 2
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<210> 3
<211> 777
<212> DNA
<213> Isochrysis galbana
<220>
<221> CDS
<222> (1)..(777)
<223> delta-9-elongase
<400> 3
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<210> 4
<211> 258
<212> PRT
<213> Isochrysis galbana
<400> 4
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<210> 5
<211> 1410
<212> DNA
<213> Phaeodactylum tricornutum
<220>
<221> CDS
<222> (1)..(1410)
<223> delta-5-desaturase
<400> 5
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<210> 6
<211> 469
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<212> PRT
<213> Phaeodactylum tricornutum
<400> 6
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<210> 7
<211> 1344
<212> DNA
<213> Ceratodon purpureus
<220>
<221> CDS
<222> (1)..(1344)
<223> delta-5-desaturase
<400> 7
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<210> 8
<211> 447
<212> PRT
<213> Ceratodon purpureus
<400> 8
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<210> 9
<211> 1443
<212> DNA
<213> Physcomitrella patens
<220>
<221> CDS
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<222> (1)..(1443)
<223> delta-5-desaturase
<400> 9
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<210> 10
<211> 480
<212> PRT
<213> Physcomitrella patens
<400> 10
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Claims
1. A process for the production of compounds of the following general formula I
in transgenic oil producing plant with a content of at least 1 % by weight of said compounds referred to the total lipid
content of said oil producing plant which comprises the following steps:
a) introduction of at least one nucleic acid in a transgenic oil producing plant, which encodes a Δ-9-elongase
having the sequence SEQ ID NO:3, and
b) introduction of at least one second nucleic acid which encodes a Δ-8-desaturase having the sequence SEQ
ID NO:1, and
c) if necessary introduction of at least a third nucleic acid, which encodes a Δ-5-desaturase having the sequence
SEQ ID NO:5, 7 or 9, and
d) cultivating and harvesting of said oil producing plant; and
where the variables and substituents in formula I have the following meanings:
R1 = hydroxyl-, Coenzyme A-(Thioester), phosphatidylcholine-, phosphatidyl-ethanolamine-, phosphatidylglyc-
erol-, diphosphatidylglycerol-, phosphatidylserine-, phosphatidylinositol-, sphingolipid-, glycoshingolipid- or a
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residue of the general formula II:
R2 = hydrogen-, phosphatidylcholine-, phosphatidylethanolamine-, phosphatidylglycerol-,
diphosphatidylglycerol-, phosphatidylserine-, phosphatidylinositol-, shingolipid-, glycoshingolipid-, glycoshin-
golipid- or saturated or unsaturated C2-C24-alkylcarbonyl-,
R3 = hydrogen-, saturated or unsaturated C2-C24-alkylcarbonyl-, or R2 and R3 independent of each other a
residue of the formula Ia:
n = 3,4 or 6, m = 3, 4 or 5 and p = 0 or 3.
2. The process as claimed in claim 1, wherein the substituents R2 and R3 are independent of each other saturated or
unsaturated C10-C22-alkylcarbonyl-.
3. The process as claimed in any of the claims 1 to 2, wherein the substituents R2 and R3 are independent of each
other saturated or unsaturated C16-, C18-, C20- or C22-alkyl-carbonyl-.
4. The process as claimed in any of the claims 1 to 3, wherein the substituents R2 and R3 are independent of each
other unsaturated C16-, C18-, C20- or C22-alkylcarbonyl- with at least three double bonds.
5. The process as claimed in any of the claims 1 to 4, wherein the transgenic plant is selected from the group consisting
of rapeseed, poppy, mustard, hemp, castor bean, sesame, olive, calendula, punica, hazel nut, almond, macadamia,
avocado, pumpkin, walnut, laurel, pistachio, primrose, canola, peanut, linseed, soybean, safflower, sunflower and
borage.
6. The process as claimed in any of the claims 1 to 5, wherein the compounds of the general formula I are isolated in
the form of their oils, lipids of free fatty acids.
7. The process as claimed in any of the claims 1 to 6, wherein the compounds of the general formula I are isolated in
a concentration of at least 5 % by weight referred to the total lipid content.
8. An isolated nucleic acid comprising a nucleotide sequence which encodes a Δ-8-desaturase having a nucleic acid
sequence depicted in SEQ ID NO: 1.
9. polypeptide encoded by an isolated nucleic acid sequence as claimed in claims 8.
10. A gene construct comprising an isolated nucleic acid having the sequence SEQ ID NO: 1, where the nucleic acid
is functionally linked to one or more regulatory signals.
11. An oil producing plant comprising at least one nucleic acid as claimed in claim 8 or a gene construct as claimed in
claim 10.
EP 1 576 166 B1
53
5
10
15
20
25
30
35
40
45
50
55
Patentansprüche
1. Verfahren zum Herstellen von Verbindungen der
folgenden allgemeinen Formel I
in einer transgenen ölproduzierenden Pflanze mit einem Gehalt von wenigstens 1 Gew.-% an den Verbindungen
bezogen auf den Gesamtlipidgehalt der ölproduzierenden Pflanze, umfassend folgende Schritte:
a) Einführen wenigstens einer Nukleinsäure, die eine Δ-9-Elongase kodiert, mit der Sequenz SEQ ID NO:3 in
eine transgene ölproduzierende Pflanze und
b) Einführen wenigstens einer zweiten Nukleinsäure, die eine Δ-8-Desaturase kodiert, mit der Sequenz SEQ
ID NO:1 und
c) nötigenfalls Einführen wenigstens einer dritten Nukleinsäure, die eine Δ-5-Desaturase kodiert, mit der Se-
quenz SEQ ID NO:5, 7 oder 9 und
d) Kultivieren und Ernten der ölproduzierenden
Pflanze; und
wobei die Variablen und Substituenten in Formel I folgende Bedeutungen haben:
R1 = Hydroxy-, Coenzym A- (Thioester),
Phosphatidylcholin-, Phosphatidyl-, Ethanolamin-, Phosphatidylglycerol-, Diphosphatidylglycerol-, Phosphati-
dylserin-, Phosphatidylinositol-, Sphingolipid-, Glycosphingolipid- oder ein Rest der allgemeinen Formel II:
R2 = Wasserstoff-, Phosphatidylcholin-,
Phosphatidylethanolamin-, Phosphatidylglycerol-, Diphosphatidylglycerol-, Phosphatidylserin-, Phosphatidyli-
nositol-, Sphingolipid-, Glycosphingolipid-, Glycosphingolipid- oder gesättigtes oder nichtgesättigtes C2-C24-Al-
kylcarbonyl,
R3 = Wasserstoff-, gesättigtes oder
nichtgesättigtes C2-C24-Alkylcarbonyl-, oder R2 und R3 sind unabhängig voneinander ein Rest der Formel Ia:
n = 3, 4 oder 6, m = 3, 4 oder 5 und p = 0 oder 3.
2. Verfahren gemäß Anspruch 1, wobei die Substituenten R2 und R3 unabhängig voneinander gesättigtes oder nicht-
gesättigtes C10-C22-Alkylcarbonyl- sind.
3. Verfahren gemäß einem der Ansprüche 1 bis 2, wobei die Substituenten R2 und R3 unabhängig voneinander ge-
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sättigtes oder nichtgesättigtes C16-, C18-, C20-oder C22-Alkylcarbonyl- sind.
4. Verfahren gemäß einem der Ansprüche 1 bis 3, wobei die Substituenten R2 und R3 unabhängig voneinander nicht-
gesättigtes C16-, C18-, C20- oder C22-Alkylcarbonyl- mit wenigstens drei Doppelbindungen sind.
5. Verfahren gemäß einem der Ansprüche 1 bis 4, wobei die transgene Pflanze ausgewählt ist aus der Gruppe beste-
hend aus Raps, Mohn, Senf, Hanf, Castorbohne, Sesam, Olive, Calendula, Punica, Haselnuss, Mandel, Macadamia,
Avocado, Kürbis, Walnuss, Lorbeer, Pistazie, Primel, Canola, Erdnuss, Leinsamen, Sojabohne, Distel, Sonnenblume
und Borago.
6. Verfahren gemäß einem der Ansprüche 1 bis 5, wobei die Verbindungen der allgemeinen Formel I in der Form ihrer
Öle, Lipide von freien Fettsäuren isoliert werden.
7. Verfahren gemäß einem der Ansprüche 1 bis 6, wobei die Verbindungen der allgemeinen Formel I in einer Kon-
zentration von wenigstens 5 Gew.-% bezogen auf den Gesamtlipidgehalt isoliert werden.
8. Isolierte Nukleinsäure, umfassend eine Nulkeotidsequenz, die eine Δ-8-Desaturase kodiert, mit der in SEQ ID NO:1
dargestellten Sequenz.
9. Polypeptid, kodiert von einer isolierten Nukleinsäuresequenz gemäß Anspruch 8.
10. Genkonstrukt, umfassend eine isolierte Nukleinsäure mit der Sequenz SEQ ID NO:1, wobei die Nukleinsäure mit
einem oder mehreren regulatorischen Signalen funktionell verbunden ist.
11. Ölproduzierende Pflanze, umfassend wenigstens eine Nukleinsäure gemäß Anspruch 8 oder ein Genkonstrukt
gemäß Anspruch 10.
Revendications
1. Procédé pour la production de composés de la formule générale suivante I :
dans une plante oléagineuse transgénique ayant une teneur d’au moins 1 % en poids desdits composés par rapport
à la teneur totale en lipides de ladite plante oléagineuse qui comprend les étapes suivantes :
a) introduction d’au moins un acide nucléique dans une plante oléagineuse transgénique qui code pour une
Δ9-élongase ayant la séquence SEQ ID NO: 3, et
b) introduction d’au moins un deuxième activités qui code pour une Δ-8-désaturase ayant la séquence SEQ ID
NO: 1, et
c) si nécessaire, introduction d’au moins un troisième acide nucléique, qui code pour une Δ-5-désaturase ayant
la séquence SEQ ID NO: 5, 7 ou 9, et
d) culture et récolte de ladite plante oléagineuse ;
et
les variables et substituants dans la formule I ont les définitions suivantes :
R1 = hydroxyl-, coenzyme A-(thioester), phosphatidylcholine-, phosphatidyléthanolamine-, phosphatidylglycé-
rol-, diphosphatidylglycérol-, phosphatidylsérine-, phosphatidylinositol-, sphingolipide-, glycosphingolipide-, ou
un résidu de formule générale II :
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R2 = hydrogène-, phosphatidylcholine-, phosphatidyléthanolamine-, phosphatidylglycérol-, diphosphatidylgly-
cérol-, phosphaatidylsérine-, phosphatidylinositol-, sphingolipide-, glycosphingolipide- ou (alkyle en C2-C24)-car-
bonyle saturé ou insaturé,
R3 = hydrogène-, (alkyle en C2-C24)-carbonyle saturé ou insaturé, ou R2 et R3 indépendamment l’un de l’autre
un résidu de formule Ia :
n = 3, 4 ou 6, m = 3, 4 ou 5 et p = 0 ou 3.
2. Procédé selon la revendication 1, dans lequel les substituants R2 et R3 sont indépendamment l’un de l’autre un
(alkyle en C10-C22)-carbonyle saturé ou insaturé.
3. Procédé selon l’une quelconque des revendications 1 à 2, dans lequel les substituants R2 et R3 sont indépendamment
l’un de l’autre un (alkyle en C16, C18, C20 ou C22)-carbonyle saturé ou insaturé.
4. Procédé selon l’une quelconque des revendications 1 à 3, dans lequel les substituants R2 et R3 sont indépendamment
l’un de l’autre un (alkyle en C16, C18, C20 ou C22)-carbonyle insaturé avec au moins trois doubles liaisons.
5. Procédé selon l’une quelconque des revendications 1 à 4, dans lequel la plante transgénique est choisie dans le
groupe constitué du colza, du pavot, de la moutarde, du chanvre, du ricin, du sésame, de l’olive, du Calendula, du
Punica, de la noisette, de la noix de macadamia, de l’avocat, de la citrouille, de la noix, du laurier, de la pistache,
de l’onagre, du canola, de l’arachide, du lin, du soja, du carthame, du tournesol et de la bourrache.
6. Procédé selon l’une quelconque des revendications 1 à 5, dans lequel les composés de la formule générale I sont
isolés sous la forme de leurs huiles, lipides ou acides gras libres.
7. Procédé selon l’une quelconque des revendications 1 à 6, dans lequel les composés de la formule générale I sont
isolés à une concentration d’au moins 5 % en poids par rapport à la teneur en lipide totale.
8. Acide nucléique isolé comprenant une séquence nucléotidique qui code pour une Δ-8-désaturase ayant une sé-
quence d’acide nucléique décrite dans SEQ ID NO: 1.
9. Polypeptide codé par une séquence d’acide nucléique isolée selon la revendication 8.
10. Construction génique comprenant un acide nucléique isolé ayant la séquence SEQ ID NO: 1, l’acide nucléique étant
fonctionnellement lié à un ou plusieurs signaux régulateurs.
11. Plante oléagineuse comprenant au moins un acide nucléique selon la revendication 8 ou une construction génique
selon la revendication 10.
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